7Baggers

Alphatec Holdings, Inc
(NASDAQ:ATEC) 

ATEC stock logo

Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders. The company offers SafeOp Neural InformatiX System, an Alpha InformatiX product platform designed to reduce the risk of intraoperative nerve injury; squ...

Founded: 1990
Full Time Employees: 227
Sector: Healthcare
Industry: Medical Devices

Share this website to your friends
• Market Cap:
• Exchange:
• Shs Outstanding:
• Employees:
• Beta:
• Return on Equity (ROE) ttm:
• Return on Assets (ROA) ttm:
• EPS ttm:
• Book value per Share:
• Cash per Share:
• Current ast per Share:
• P/E ttm:
• P/E forward:
• P/E ttm high:
• P/E ttm low:
• P/S ttm:
• P/B ttm:
• P/FCF ttm:
• PEG ratio:
• Cash Ratio ttm:
• Quick Ratio ttm:
• Current Ratio ttm:
• Gross Mgn ttm:
• EBITDA Mgn ttm:
• Operating Mgn ttm:
• Net Income Mgn ttm:
• Trailing Div yield:
• Forward Div yield:
• Payout Ratio ttm:
• Ex-Dividend date:
• Target Price High:
• Target Price Low:
• Target Price Mean:
• Number of Analysts:
• Debt Ratio ttm:
• Debt to Equity ttm:
• Total Net Debt:
At a glance:
Bull Thesis:
Bear Thesis:
Main Competitors:
Moat:
Income Statements:
Quarterly
Annual
    Unit: USD2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31 2009-12-31 2009-09-30 2009-06-30 2009-03-31 2008-12-31 2008-09-30 2008-06-30 2008-03-31 2007-12-31 2007-09-30 2007-06-30 2007-03-31 2006-12-31 2006-09-30 2006-06-30 
                                                                                    
      revenue from products and services
    192,108,000 212,928,000 196,503,000 185,544,000 169,180,000 176,793,000 150,719,000 145,573,000 138,477,000 137,970,000 118,262,000 116,920,000 109,110,000 105,944,000 89,839,000 84,151,000 70,918,000 73,922,000 62,735,000 61,885,000                                                             
      yoy
    13.55% 20.44% 30.38% 27.46% 22.17% 28.14% 27.44% 24.51% 26.92% 30.23% 31.64% 38.94% 53.85% 43.32% 43.20% 35.98%                                                                 
      qoq
    -9.78% 8.36% 5.91% 9.67% -4.31% 17.30% 3.53% 5.12% 0.37% 16.66% 1.15% 7.16% 2.99% 17.93% 6.76% 18.66% -4.06% 17.83% 1.37%                                                              
      cost of sales
    55,632,000 63,437,000 59,203,000 56,443,000 53,184,000 55,205,000 47,990,000 42,979,000 41,126,000 42,780,000 38,215,000 52,379,000 38,685,000 37,093,000 30,323,000 28,675,000 21,717,000                                                                
      gross profit
    136,476,000 149,491,000 137,300,000 129,101,000 115,996,000 121,588,000 102,729,000 102,594,000 97,351,000 95,190,000 80,047,000 64,541,000 70,425,000 68,851,000 59,516,000 55,476,000 49,216,000 45,225,000 39,614,000 41,065,000 31,858,000 31,391,000 29,237,000 20,842,000 21,031,000 22,207,000 19,933,000 18,886,000 16,568,000 20,483,000 14,914,000 14,270,000 13,570,000 15,294,000 14,512,000 15,748,000 16,779,000 14,627,000 15,862,000 27,918,000 30,869,000 31,135,000 28,479,000 27,527,000 32,943,000 37,690,000 36,306,000 36,120,000 33,294,000 35,255,000 24,232,000 32,093,000 32,742,000 32,120,000 29,633,000 30,196,000 31,819,000 24,911,000 30,207,000 29,861,000 31,951,000 31,483,000 28,927,000 28,833,000 23,966,000 22,699,000 20,811,000 20,851,000 19,780,000 16,853,000 16,708,000 15,837,000 15,310,000 12,614,000 12,940,000 11,984,000 12,669,000 13,079,000 10,752,000 12,855,000 
      yoy
    17.66% 22.95% 33.65% 25.84% 19.15% 27.73% 28.34% 58.96% 38.23% 38.26% 34.50% 16.34% 43.09% 52.24% 50.24% 35.09% 54.49% 44.07% 35.49% 97.03% 51.48% 41.36% 46.68% 10.36% 26.94% 8.42% 33.65% 32.35% 22.09% 33.93% 2.77% -9.39% -19.13% 4.56% -8.51% -43.59% -45.64% -53.02% -44.30% 1.42% -6.30% -17.39% -21.56% -23.79% -1.05% 6.91% 49.83% 12.55% 1.69% 9.76% -18.23% 6.28% 2.90% 28.94% -1.90% 1.12% -0.41% -20.87% 4.42% 3.57% 33.32% 38.70% 39.00% 38.28% 21.16% 34.69% 24.56% 31.66% 29.20% 33.61% 29.12% 32.15% 20.85% -3.56% 20.35% -6.78%     
      qoq
    -8.71% 8.88% 6.35% 11.30% -4.60% 18.36% 0.13% 5.39% 2.27% 18.92% 24.03% -8.35% 2.29% 15.68% 7.28% 12.72% 8.82% 14.16% -3.53% 28.90% 1.49% 7.37% 40.28% -0.90% -5.30% 11.41% 5.54% 13.99% -19.11% 37.34% 4.51% 5.16% -11.27% 5.39% -7.85% -6.14% 14.71% -7.79% -43.18% -9.56% -0.85% 9.33% 3.46% -16.44% -12.59% 3.81% 0.51% 8.49% -5.56% 45.49% -24.49% -1.98% 1.94% 8.39% -1.86% -5.10% 27.73% -17.53% 1.16% -6.54% 1.49% 8.84% 0.33% 20.31% 5.58% 9.07% -0.19% 5.41% 17.37% 0.87% 5.50% 3.44% 21.37% -2.52% 7.98% -5.41% -3.13% 21.64% -16.36%  
      gross margin %
    71.04% 70.21% 69.87% 69.58% 68.56% 68.77% 68.16% 70.48% 70.30% 68.99% 67.69% 55.20% 64.54% 64.99% 66.25% 65.92% 69.40% 61.18% 63.14% 66.36% Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% 
      operating expenses:
                                                                                    
      research and development
    17,560,000 22,281,000 18,679,000 18,276,000 16,582,000 23,244,000 20,357,000 19,105,000 18,012,000 22,284,000 20,000,000 14,571,000 13,260,000 11,604,000 12,111,000 10,596,000 9,722,000 8,984,000 9,391,000 7,839,000 5,801,000 6,945,000 4,379,000 3,672,000 3,749,000 3,058,000 3,962,000 3,360,000 3,469,000 3,032,000 3,157,000 2,009,000 1,786,000 1,437,000 1,044,000 990,000 1,449,000 2,449,000 1,087,000 2,080,000 3,667,000 8,106,000 1,898,000 3,912,000 3,851,000 3,661,000 4,423,000 4,534,000 4,181,000 3,814,000 3,028,000 3,666,000 3,682,000 3,883,000 3,216,000 3,777,000 4,010,000 3,235,000 3,858,000 4,382,000 5,413,000 4,084,000 3,751,000 4,909,000 3,687,000 3,554,000 3,630,000 3,436,000 2,867,000 3,046,000 3,361,000 3,354,000 3,204,000 2,255,000 1,336,000 1,303,000 1,465,000 1,013,000 1,016,000 856,000 
      sales, general and administrative
    137,057,000 128,699,000 124,303,000 118,507,000 127,017,000 114,541,000 109,200,000 112,731,000 113,727,000 104,120,000 91,411,000 87,287,000 91,262,000 81,920,000 75,954,000 72,668,000 69,471,000 66,693,000 61,494,000 60,659,000 40,426,000 38,135,000 35,985,000 27,033,000 28,003,000 29,354,000 26,792,000 24,568,000 21,000,000                                                    
      litigation-related expenses
    525,000 3,457,000 6,520,000 1,593,000 12,214,000 1,188,000 2,093,000 2,090,000 4,428,000 9,472,000 2,715,000 6,908,000 3,192,000 7,314,000 3,602,000 5,495,000 7,532,000 5,412,000 1,209,000 1,167,000        1,200,000 2,623,000                                                    
      amortization of acquired intangible assets
    3,915,000 3,873,000 3,731,000 3,803,000  2,884,500 3,848,000 3,836,000 3,854,000 3,823,000 3,873,000 3,705,000 2,883,000 2,934,000 2,774,000 2,177,000 2,230,000 1,956,000 2,012,000 1,208,000 172,000 172,000 172,000 172,000              62,250 83,000 377,000 360,000 360,000 363,000 361,000 369,000 408,000 435,000 447,000 446,000 444,000 432,000 426,000 431,000 635,000 362,000 373,000 379,000 390,000 411,000 416,000 396,000 394,000 373,000 369,000                 
      restructuring expenses
       7,000 371,000 1,386,000 934,000 139,000 788,000 386,000 129,000 29,000 175,000 106,000 45,000 289,000 1,370,000 110,000 256,000          60,000 623,000 167,000 193,000 398,000 308,000 139,000 528,000 1,231,000 514,000 1,605,000 103,000 686,000 1,025,000 335,000 -112,000 -60,000  20,000  776,000 5,620,000 4,045,000       57,000 394,000  599,000 -7,000 702,000 805,000 882,000                
      total operating expenses
    159,057,000 158,310,000 153,233,000 142,186,000 160,287,000 145,406,000 136,432,000 137,901,000 140,692,000 140,020,000 118,406,000 114,400,000 110,772,000 103,878,000 94,486,000 91,225,000 90,445,000 83,364,000 74,735,000 76,817,000 50,904,000 48,427,000 42,098,000 32,000,000 38,839,000 36,706,000 31,530,000 29,300,000 27,334,000 28,178,000 22,447,000 20,815,000 14,237,000 18,902,000 15,773,000 16,483,000 20,178,000 21,691,000 20,411,000 29,082,000 34,608,000 36,941,000 193,427,000 30,354,000 31,801,000 34,717,000 34,574,000 34,279,000 37,996,000 91,257,000 37,406,000 34,992,000 34,100,000 36,107,000 31,607,000 33,947,000 31,945,000 41,399,000 32,569,000 33,165,000 34,313,000 33,179,000 32,402,000 31,890,000 27,597,000 23,024,000 21,468,000 26,302,000 22,904,000 21,024,000 21,163,000 19,156,000 31,171,000 23,770,000 18,308,000 12,534,000 15,281,000 22,663,000 16,361,000 16,665,000 
      operating income
    -22,581,000 -8,819,000 -15,933,000 -13,085,000 -44,291,000 -23,818,000 -33,703,000 -35,307,000 -43,341,000 -44,830,000 -38,359,000 -49,859,000 -40,347,000 -35,027,000 -34,970,000 -35,749,000 -41,229,000 -38,139,000 -35,121,000 -35,752,000 -19,046,000 -17,036,000 -12,861,000 -11,158,000 -17,808,000 -14,499,000 -11,597,000 -10,414,000 -10,766,000 -7,695,000 -7,533,000 -6,545,000 -667,000 -3,608,000 -1,261,000 -735,000 -3,399,000 -7,064,000 -4,549,000 -1,164,000 -3,739,000 -5,806,000 -164,948,000 -2,827,000 1,142,000 2,973,000 1,732,000 1,841,000 -4,702,000 -56,002,000 -13,174,000 -2,899,000 -1,358,000 -3,987,000 -1,974,000 -3,751,000 -126,000 -16,488,000 -2,362,000 -3,304,000 -2,362,000 -1,696,000 -3,475,000 -3,057,000 -3,631,000 -325,000 -657,000 -5,451,000 -3,124,000 -4,171,000 -4,455,000 -3,319,000 -15,861,000 -11,156,000 -5,368,000 -550,000 -2,612,000 -9,584,000 -5,609,000  
      yoy
    -49.02% -62.97% -52.73% -62.94% 2.19% -46.87% -12.14% -29.19% 7.42% 27.99% 9.69% 39.47% -2.14% -8.16% -0.43% -0.01% 116.47% 123.87% 173.08% 220.42% 6.95% 17.50% 10.90% 7.14% 65.41% 88.42% 53.95% 59.11% 1514.09% 113.28% 497.38% 790.48% -80.38% -48.92% -72.28% -36.86% -9.09% 21.67% -97.24% -58.83% -427.41% -295.29% -9623.56% -253.56% -124.29% -105.31% -113.15% -163.50% 246.24% 1304.61% 567.38% -22.71% 977.78% -75.82% -16.43% 13.53% -94.67% 872.17% -32.03% 8.08% -34.95% 421.85% 428.92% -43.92% 16.23% -92.21% -85.25% 64.24% -80.30% -62.61% -17.01% 503.45% 507.24% 16.40% -4.30%      
      qoq
    156.05% -44.65% 21.77% -70.46% 85.96% -29.33% -4.54% -18.54% -3.32% 16.87% -23.07% 23.58% 15.19% 0.16% -2.18% -13.29% 8.10% 8.59% -1.76% 87.71% 11.80% 32.46% 15.26% -37.34% 22.82% 25.02% 11.36% -3.27% 39.91% 2.15% 15.10% 881.26% -81.51% 186.12% 71.56% -78.38% -51.88% 55.29% 290.81% -68.87% -35.60% -96.48% 5734.74% -347.55% -61.59% 71.65% -5.92% -139.15% -91.60% 325.09% 354.43% 113.48% -65.94% 101.98% -47.37% 2876.98% -99.24% 598.05% -28.51% 39.88% 39.27% -51.19% 13.67% -15.81% 1017.23% -50.53% -87.95% 74.49% -25.10% -6.37% 34.23% -79.07% 42.17% 107.82% 876.00% -78.94% -72.75% 70.87%   
      operating margin %
    -11.75% -4.14% -8.11% -7.05% -26.18% -13.47% -22.36% -24.25% -31.30% -32.49% -32.44% -42.64% -36.98% -33.06% -38.93% -42.48% -58.14% -51.59% -55.98% -57.77% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% Infinity% Infinity% Infinity% Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% NaN% 
      other expense, net:
                                                                                    
      interest expense
    -11,721,000 -12,894,000 -12,878,000 -12,309,000 -7,841,000 -7,151,000 -6,572,000 -5,815,000 -5,341,000 -4,416,000 -4,459,000 -3,892,000 -3,874,000 -1,329,000 -1,285,000 -1,435,000 -1,456,000 -1,504,000 -1,272,000 -2,394,000 -1,938,000 -3,706,000 -2,762,000         -1,709,000 -1,707,000 -1,813,000 -1,807,000 -1,881,000 -1,981,000 -2,250,000 -1,123,000 -3,724,000 -3,357,000 -3,068,000 -3,110,000 -3,040,000 -3,371,000 -4,306,000 -3,875,000 -3,747,000 -1,688,000 -1,289,000 -1,048,000 -927,000 -695,000 -1,045,000 -774,000 -3,578,000 -708,000 -735,000 -725,000 -888,000 -679,000 -2,224,000 -1,417,000 -1,444,000 -862,000 -713,000 -935,000 -918,000 -916,000 -1,161,000 -266,000 -269,000 -178,000 -149,000 -156,000 -225,000 -338,000    
      loss on debt extinguishment
        -17,576,000              -7,434,000   -6,057,000  -1,555,000               -9,478,000                                          
      gain on derivative liability
       -16,780,000 17,400,000                                                                            
      other income
    446,000 -34,000 307,000 993,000 337,000 -1,922,000 623,000 156,000 118,000 44,000 47,000 2,324,000 706,000 1,049,000 -615,000 67,000  -255,000 886,000   -1,500 -6,000         -75,000 62,000 -2,000 -15,000 2,000 5,000 -442,000 90,000 239,000 1,045,000 198,000 6,058,000 2,161,000 -1,437,000 -307,500 -928,000 -685,000 383,000 -822,000 210,000 -400,000 -650,000 -733,000 208,000 -9,000 -259,000 -251,000 202,000 335,000 421,000 105,000 70,000 1,101,000 -110,000 -278,000 287,000 166,000 -261,000 474,000 -100,000 -38,000 151,000 2,000 60,000 -2,000 90,000    
      total other expense
    -11,275,000 -12,928,000 -12,571,000 -28,096,000 -7,680,000 -9,073,000 -5,949,000 -5,659,000 -5,223,000               -4,587,000                                                         
      net loss before taxes
    -33,856,000 -21,747,000 -28,504,000 -41,181,000 -51,971,000 -32,891,000 -39,652,000 -40,966,000 -48,564,000 -49,202,000 -42,771,000 -51,427,000 -43,515,000 -35,307,000 -36,870,000 -37,117,000 -42,715,000 -40,186,000 -42,941,000 -38,162,000                                                             
      income tax provision
    50,000 -18,000 74,000      -69,000    14,000 -321,000 129,000 203,000 129,000 1,000 90,000 43,000 30,000 5,000 40,000 60,000 40,000    31,000 -424,250 26,000 -1,265,000 -458,000 14,250 -7,000 15,000 49,000   600,000 586,000 1,243,000 -1,717,000 253,000 902,000   307,000 669,000 2,296,000 500,000          -749,000   -265,000 112,000 13,000 -2,000 116,000 116,000 225,000 82,000 69,000 92,000 312,000 221,000 56,000 1,000 334,000   
      net income
    -33,906,000 -21,729,000 -28,578,000 -41,144,000 -51,907,000 -33,332,000 -39,616,000 -40,680,000 -48,495,000 -49,078,000 -42,654,000 -51,377,000 -43,529,000 -34,986,000 -36,999,000 -37,320,000 -42,844,000 -40,187,000 -43,031,000 -38,205,000 -22,903,000 -26,798,000 -15,669,000 -15,805,000 -20,722,000 -17,031,000 -14,567,000 -12,436,000 -12,968,000 -10,628,000 -9,355,000 -7,076,000 -1,916,000 9,055,000 -3,137,000 -2,697,000 -5,515,000 -4,354,000 -13,721,000 -5,233,000 -6,617,000 -9,903,000 -160,265,000 -3,947,000 -4,561,000 -273,000 -3,041,000 -2,895,000 -6,673,000 -60,407,000 -14,510,000 -4,661,000 -2,649,000 -5,355,000 -2,469,000 -6,374,000 -1,261,000 -15,966,000 -1,304,000 -3,044,000 -1,867,000 -2,876,000 -3,790,000 -2,979,000 -4,710,000 -1,320,000 -1,283,000 -6,303,000 -4,383,000 -5,058,000 -4,860,000 -3,591,000 -15,779,000 -11,247,000 -5,578,000 -703,000 -2,674,000 -11,324,000 -5,438,000  
      yoy
    -34.68% -34.81% -27.86% 1.14% 7.04% -32.08% -7.12% -20.82% 11.41% 40.28% 15.28% 37.67% 1.60% -12.94% -14.02% -2.32% 87.07% 49.96% 174.63% 141.73% 10.53% 57.35% 7.57% 27.09% 59.79% 60.25% 55.71% 75.75% 576.83% -217.37% 198.21% 162.37% -65.26% -307.97% -77.14% -48.46% -16.65% -56.03% -91.44% 32.58% 45.08% 3527.47% 5170.14% 36.34% -31.65% -99.55% -79.04% -37.89% 151.91% 1028.05% 487.69% -26.87% 110.07% -66.46% 89.34% 109.40% -32.46% 455.15% -65.59% 2.18% -60.36% 117.88% 195.40% -52.74% 7.46% -73.90% -73.60% 75.52% -72.22% -55.03% -12.87% 410.81% 490.09% -0.68% 2.57%      
      qoq
    56.04% -23.97% -30.54% -20.74% 55.73% -15.86% -2.62% -16.12% -1.19% 15.06% -16.98% 18.03% 24.42% -5.44% -0.86% -12.89% 6.61% -6.61% 12.63% 66.81% -14.53% 71.03% -0.86% -23.73% 21.67% 16.91% 17.14% -4.10% 22.02% 13.61% 32.21% 269.31% -121.16% -388.65% 16.31% -51.10% 26.67% -68.27% 162.20% -20.92% -33.18% -93.82% 3960.43% -13.46% 1570.70% -91.02% 5.04% -56.62% -88.95% 316.31% 211.31% 75.95% -50.53% 116.89% -61.26% 405.47% -92.10% 1124.39% -57.16% 63.04% -35.08% -24.12% 27.22% -36.75% 256.82% 2.88% -79.64% 43.81% -13.35% 4.07% 35.34% -77.24% 40.30% 101.63% 693.46% -73.71% -76.39% 108.24%   
      net income margin %
    -17.65% -10.20% -14.54% -22.17% -30.68% -18.85% -26.28% -27.94% -35.02% -35.57% -36.07% -43.94% -39.89% -33.02% -41.18% -44.35% -60.41% -54.36% -68.59% -61.74% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% NaN% 
      net income per share
    -0.22 -0.15 -0.19 -0.27 -0.35 -0.23 -0.28 -0.29 -0.34 -0.36 -0.35 -0.43 -0.4 -0.33 -0.35 -0.36 -0.43 -0.41 -0.43 -0.39 -0.26 -0.36 -0.24 -0.25 -0.33 -0.28 -0.26 -0.27 -0.29 -0.64 -0.22 -0.21 -0.09 0.82 -0.23 -0.24 -0.61 -0.48 -1.6                                         -0.2 
      weighted-average shares outstanding, basic and diluted
    154,051 150,064 151,401 149,907 146,732 142,946 143,492 142,687 140,980 121,242 122,468 118,719 109,751 103,373 104,804 102,849 99,978 96,197 99,571 98,541                                                             
      income tax benefit
       -37,000 -64,000 -97,750 -36,000 -286,000  -124,000 -117,000 -50,000              -361,000 20,000 71,000          -1,240,500 -4,997,000       237,000 -28,000     435,000 -52,000 -400,000 -38,000 -928,000 207,000 -761,000 -1,533,000 -762,000  -224,750 -770,000                  
      amortization expense
        4,103,000                                                                            
      transaction-related expenses
         327,000   -117,000 -65,000 278,000 1,900,000     120,000 209,000 373,000 4,771,000          4,000 66,000 -62,000 1,542,000                                                
      revenue:
                                                                                    
      revenue from international supply agreement
                    15,000 40,000 145,000 364,000 405,000 831,000 1,111,000 795,000 1,045,000 1,209,000 1,150,000 1,226,000 1,600,000                                                    
      total revenue
             137,970,000 118,262,000 116,920,000 109,110,000 105,944,000 89,839,000 84,151,000 70,933,000 73,962,000 62,880,000 62,249,000 44,121,000 25,226,750 41,163,000 29,629,000 30,115,000                                                        
      interest expense and other expense, net:
                                                                                    
      total interest expense and other expense
             -2,287,000 -4,412,000                                                                      
      interest expense and other income, net:
                                                                                    
      total interest expense and other income
               -1,568,000                                                                     
      interest and other expense, net:
                                                                                    
      total interest and other expense
                -3,168,000 -280,000 -1,900,000 -1,368,000 -1,486,000 -2,047,000 -7,820,000 -2,410,000 -3,827,000                                                            
      other expense
                    -30,000   -16,000     -2,874,000                                                        
      cost of revenue
                     14,178,250 23,266,000 21,184,000 12,263,000 7,449,250 11,926,000 8,787,000 9,084,000                                                        
      restructuring costs
                       1,173,000                                                             
      revenue from u.s. products
                        43,716,000 43,123,000 40,052,000 28,834,000 29,070,000 31,143,000 28,051,000 26,093,000 22,955,000                                                    
      litigation-related
                        3,335,000 3,045,000 1,560,000 1,304,000 2,643,000                                                        
      transaction-related
                        1,012,000 130,000 2,000 -181,000 4,272,000                                                        
      restructuring
                        158,000                                                            
      other expenses
                        -1,889,000                                                            
      loss from continuing operations before taxes
                        -22,873,000   -15,745,000 -20,682,000    -12,885,000 -4,982,000 -9,287,000 -8,329,000 -2,312,000 -2,768,000 -3,083,000 -2,614,000  -5,295,500 -15,060,000           -5,234,250 -14,010,000       -17,429,000 -2,837,000 -3,806,000 -2,616,000 -4,031,000 -4,560,000 -3,366,000                 
      loss from continuing operations
                        -22,903,000   -15,805,000 -20,722,000    -12,916,000 -4,557,750 -9,313,000 -7,064,000 -1,854,000 -2,782,250 -3,076,000 -2,629,000                      -15,966,000 -1,304,000 -3,044,000 -1,867,000 -2,876,000 -3,790,000 -3,101,000                 
      shares used in calculating basic and diluted net loss per share
                        87,223   63,713 62,568    45,020 8,164.5 42,497 34,030 21,212 2,837.25 13,938 11,047  2,126.25 8,560  101,586    99,020                                    
      interest and other income, net:
                                                                                    
      total interest and other income
                         -2,557,250 -2,768,000                                                          
      income from continuing operations before taxes
                         -13,014,000 -15,629,000   -17,398,000 -14,523,000 -12,335,000         -5,375,000               -4,226,000  -5,755,000 -2,507,000 -7,302,000                         
      income from continuing operations
                         -13,049,000 -15,669,000   -17,037,000 -14,543,000 -12,406,000         -5,424,000                                            
      income from discontinued operations, net of applicable taxes
                             6,000 -24,000 -30,000         -91,000                                            
      continuing operations
                         -0.36 -0.24 -0.25 -0.33 -0.28 -0.26 -0.26 -0.29 -0.26 -0.22 -0.21 -0.09 0.62 -0.22 -0.24 -0.6 -1.15 -1.17                                          
      discontinued operations
                                     0.2 -0.01 -0.01 -0.01 0.68 -0.43                                          
      shares used in calculating basic and diluted net income per share
                         15,917.25 64,761   2,982 55,736 46,880         9,005   101,856    99,258                                     
      other expense:
                                                                                    
      interest and other expense
                           -3,032,000      -1,295,750 -1,754,000                                                  
      loss from discontinued operations, net of applicable taxes
                                -52,000 -29,000 -42,000 -12,000 -62,000 -55,000 -61,000 -68,000                                             
      amortization of intangible assets
                            172,000 172,000 172,000 172,000 182,000 187,000 187,000 187,000 177,000 172,000 172,000 172,000 172,000                                            
      loss per share, basic and diluted:
                                                                                    
      revenues:
                                                                                    
      total revenues
                             32,352,000 29,201,000 27,319,000 24,555,000                                                    
      cost of revenues
                             10,145,000 9,268,000 8,433,000 7,987,000 4,860,000 8,088,000 7,772,000 7,737,000 10,989,000 8,587,000 8,631,000 11,199,000 12,463,000 10,849,000 15,495,000 13,532,000 15,508,000 14,154,000 18,745,000 15,335,000 15,529,000 14,272,000 16,600,000 15,433,000 17,366,000 25,532,000 18,501,000 17,270,000 19,988,000 16,844,000 17,666,000 16,263,000 24,209,000 17,001,000 20,585,000 17,373,000 14,141,000 15,546,000 16,222,000 14,465,000 13,907,000 11,866,000 11,412,000 10,830,000 11,594,000 9,108,000 8,016,000 7,887,000 8,728,000 7,379,000 6,836,000 6,881,000 6,117,000 6,606,000 6,567,000 
      litigation
                             1,106,750 604,000                                                      
      gain on settlement
                                    -6,168,000                                                
      total other incomes
                             -1,741,500 -2,926,000                                                      
      total other income
                               -1,921,000 -2,119,000   -1,784,000 -1,645,000 10,106,000 -1,822,000 -1,879,000 -1,976,000 -2,689,000 -10,511,000 -3,469,000 -2,292,000 -2,854,000 2,966,000 -867,000 -4,801,000 -3,107,000 -4,801,000 -4,429,000 -1,302,000 -2,109,000 -836,000 -1,327,000 -1,343,000 -1,768,000 -533,000 -3,551,000 -928,000 -941,000 -475,000 -502,000 -254,000 -2,335,000 -1,085,000 -309,000 -967,000 -982,000 -628,000 -736,000 -1,143,000 -662,000 -323,000 -203,000 174,000 221,000 11,000 -97,000 -61,000    
      revenues
                                 16,587,750 23,002,000 22,042,000 21,307,000 26,283,000 23,099,000 24,379,000 27,978,000 27,090,000 26,711,000 43,790,000 44,761,000 47,003,000 42,996,000 46,633,000 48,647,000 53,627,000 51,013,000 53,167,000 49,173,000 53,065,000 50,196,000 51,020,000 50,443,000 52,743,000 46,839,000 48,235,000 48,461,000 49,510,000 47,619,000 50,862,000 49,720,000 46,018,000 44,846,000 45,424,000 38,431,000 36,606,000 32,677,000 32,263,000 30,610,000 28,447,000 25,816,000 23,853,000 23,197,000 21,342,000 20,319,000 18,820,000 19,550,000 19,196,000 17,358,000 19,422,000 
      sales and marketing
                                 7,922,250 10,956,000 10,673,000 10,060,000 9,742,000 10,015,000 10,298,000 11,103,000 11,464,000 11,764,000 18,138,000 19,122,000 18,883,000 17,134,000 16,644,000 18,195,000 20,634,000 18,649,000 19,837,000 18,059,000 21,156,000 18,149,000 19,160,000 18,495,000 19,334,000 17,778,000 19,529,000 18,536,000 18,124,000 19,145,000 19,291,000 18,629,000 18,971,000 17,052,000 17,115,000 13,780,000 13,354,000 12,565,000 12,810,000 12,784,000 11,549,000 10,723,000 9,019,000 9,139,000 7,644,000 7,506,000 6,880,000 7,909,000 9,969,000 8,587,000 7,998,000 
      general and administrative
                                 5,542,750 7,914,000 7,815,000 6,442,000 7,243,000 4,403,000 5,351,000 6,223,000 6,579,000 4,136,000 8,270,000 10,647,000 8,394,000 8,094,000 9,241,000 9,138,000 9,705,000 10,213,000 9,241,000 14,222,000 13,931,000 11,443,000 11,445,000 11,130,000 11,225,000 9,758,000 10,132,000 8,825,000 9,660,000 8,627,000 8,938,000 9,142,000 9,578,000 7,933,000 8,007,000 5,646,000 5,566,000 5,223,000 5,563,000 5,963,000 6,279,000 5,779,000 6,783,000 6,528,000 6,871,000 7,122,000 4,351,000 5,907,000 11,681,000 6,758,000 7,811,000 
      gain on sale of assets
                                       -856,000                                             
      other income:
                                                                                    
      goodwill and intangible asset impairment
                                                                                    
      in-process research and development
                                              274,000    527,000                2,425,000 92,000 450,000 550,000 50,000 4,493,000 1,290,000 150,000 1,300,000  1,300,000 7,000,000 2,344,000      
      goodwill and intangible impairment
                                         434,000 1,736,000   41,292,750 165,171,000                                      
      net income from continuing operations
                                         -4,055,000 -10,063,000                                          
      discontinued operations:
                                                                                    
      net loss from discontinued operations, net of applicable taxes
                                         -2,337,750 -3,658,000                                          
      interest income
                                           16,000 20,000 16,000 18,000 12,000 7,000 2,000 2,000 3,000 3,000 2,000 2,000  2,000 10,000 33,000 36,000 39,000 45,000 48,000 51,000 4,000 -216,000 262,000 34,000 5,000 9,000 20,000 16,000 34,000 25,000 43,000 104,000 201,000 368,000 107,000 130,000 187,000    
      pretax net income
                                           -4,633,000    -3,694,000  -2,915,250 -3,069,000                                  
      net income per basic and diluted share
                                           -50    -40                                     
      pretax net loss
                                            -6,031,000 -42,333,750 -161,982,000  -3,659,000   -2,588,000 -6,004,000                                
      net loss per basic and diluted share
                                            -70    -50                                    
      net loss per basic share
                                             -425 -1,610                                      
      net loss per diluted share
                                             -425 -1,610                                      
      shares used in calculating basic net loss per share
                                             24,814.5 99,376                                      
      shares used in calculating diluted net loss per share
                                             24,814.5 99,376                                      
      net income per basic share
                                                 -32.5 -30                                  
      net income per diluted share
                                                 -32.5 -40                                  
      shares used in calculating basic net income per share
                                                 24,260 97,391                                  
      shares used in calculating diluted net income per share
                                                 24,314.5 98,329                                  
      restructuring expense
                                                   -90,000                                 
      net loss per common share:
                                                                                    
      basic and diluted net loss per share
                                                   -0.03 -0.07 -0.058 -0.15       -0.018 -0.01 -0.03 -0.02 -0.038 -0.04 -0.04                 
      weighted-average shares used for eps calculation
                                                                                    
      basic and diluted
                                                   96,922 96,838 96,235,000 96,381 95,926 95,826 90,218 89,503 89,218 88,938 88,798 88,829 88,740 88,697 78,590 86,990 84,675 54,153,000 49,292,000 51,516,000 47,157,000 46,503,000 46,290,000 46,387,000 46,274,000 46,001,000 37,283,000 35,634,000 33,959,000     
      transaction related expenses
                                                         718,000 364,000       20,000 6,000 493,000 3,152,000                
      net income per common share:
                                                                                    
      basic and diluted net income per share
                                                       -0.05 -0.03 -0.028 -0.03 -0.07 -0.01                        
      income before taxes
                                                        -2,701,000    -1,054,000                        
      income from discontinued operations, net of tax
                                                                   122,000                 
      basic and diluted net loss per share from continuing operations
                                                             -0.18 -0.01 -0.03 -0.02 -0.03 -0.04 -0.04                 
      basic and diluted net income per share from discontinued operations
                                                                                    
      loss from discontinued operations, net of tax
                                                                                    
      basic and diluted net loss per share from discontinued operations
                                                                                    
      net loss before non-controlling interest
                                                                 -2,869,750 -3,790,000 -2,979,000                 
      net loss attributable to non-controlling interest
                                                                                    
      loss before taxes
                                                                    -4,598,000 -1,307,000 -1,285,000 -6,187,000 -4,267,000 -4,833,000 -4,778,000 -3,522,000 -15,687,000        
      net loss per common share:
                                                                                    
      basic and diluted
                                                                    -90 -20 -20 -130 -90 -110 -100 -80 -340 -280 -160 -20     
      litigation settlement
                                                                            11,000,000        
      loss before tax
                                                                             -10,935,000 -5,357,000 -647,000 -2,673,000 -3,639,000 -5,438,000  
      accretion to redemption value of redeemable convertible preferred stock, rolling common and series c common stock
                                                                                 30,000 -30,000  
      net loss available to common stockholders
                                                                             -11,247,000 -5,578,000 -703,000 -2,674,000 -4,493,000 -5,468,000  
      net loss per common share:
                                                                                    
      basic
                                                                                -80    
      diluted
                                                                                -80    
      weighted-average shares used for eps calculation
                                                                                    
      basic
                                                                                33,493,000 27,238,000   
      diluted
                                                                                33,493,000 27,238,000   
      interest and other income
                                                                                 -506,500 171,000  
      net loss per common share - basic and diluted
                                                                                 -180 -160  
      weighted-average shares - basic and diluted
                                                                                  33,370,000  
      net loss applicable to common stockholders
                                                                                   -4,686,000 
      weighted average shares - basic and diluted
                                                                                   23,045 
    Balance Sheets:
    Quarterly
    Annual
      Unit: USD2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31 2009-12-31 2009-09-30 2009-06-30 2009-03-31 2008-12-31 2008-09-30 2008-06-30 2008-03-31 2007-12-31 2007-09-30 2007-06-30 2007-03-31 2006-12-31 2006-09-30 2006-06-30 
                                                                                     
        assets
                                                                                     
        current assets:
                                                                                     
        cash and cash equivalents
      160,806,000 155,741,000 157,063,000 153,244,000 138,840,000 80,976,000 99,828,000 144,085,000 220,970,000 122,526,000 101,020,000 116,698,000 84,696,000 106,112,000 107,470,000 151,812,000 187,248,000                                 18,654,000 12,948,000 19,293,000 22,241,000 25,941,000 22,023,000 16,859,000 20,666,000 22,144,000 21,761,000 21,477,000 23,168,000 28,854,000 38,408,000 12,662,000 10,085,000 14,110,000 19,731,000 10,087,000 18,315,000 10,874,000 13,071,000 26,904,000 25,843,000 33,661,000 6,249,000 8,090,000 16,943,000 21,360,000 25,020,000 
        accounts receivable
      97,304,000 96,838,000 95,919,000 89,481,000 82,987,000 78,452,000 83,985,000 88,648,000 72,613,000 64,519,000 59,932,000 62,415,000 60,060,000 50,723,000 43,928,000 40,438,000 41,893,000 33,676,000 33,743,000 25,751,000 23,527,000 24,270,000 19,785,000 15,375,000 16,150,000 15,430,000 13,642,000 13,760,000 15,095,000 12,204,000 11,405,000 11,960,000 14,822,000 13,303,000 13,126,000 14,212,000 18,512,000 16,546,000 36,515,000 39,436,000 38,319,000 36,252,000 38,857,000 38,914,000 40,440,000 40,053,000 44,662,000 38,838,000 41,395,000 41,738,000 41,031,000 40,711,000 41,012,000 37,565,000 38,800,000 40,570,000 41,711,000 39,775,000 41,711,000 43,341,000 39,777,000 43,151,000 37,153,000 39,268,000 24,766,000 21,744,000 23,824,000 23,812,000 18,759,000 17,391,000 15,300,000 14,183,000 13,035,000 12,807,000 11,724,000 11,903,000 10,583,000 10,417,000 13,537,000 
        inventories
      169,444,000 166,890,000 169,760,000 170,873,000 175,264,000 183,111,000 172,314,000 152,981,000 136,842,000 130,672,000 119,957,000 108,242,000 101,521,000 102,159,000 102,796,000 99,043,000 91,703,000 92,509,000 86,715,000 57,376,000 46,001,000 42,144,000 41,466,000 37,872,000 34,854,000 33,065,000 32,605,000 31,166,000 28,765,000 28,988,000 28,177,000 28,872,000 27,292,000 29,747,000 29,810,000 30,088,000 30,093,000 27,661,000 44,141,000 47,958,000 44,908,000 42,328,000 41,237,000 41,772,000 41,747,000 41,986,000 42,447,000 42,542,000 41,939,000 43,139,000 50,614,000 50,457,000 49,855,000 48,344,000 47,412,000 48,155,000 45,916,000 48,783,000 47,974,000 52,568,000 51,635,000 53,552,000 49,913,000 46,702,000 29,515,000 28,615,000 27,749,000 26,952,000 24,170,000 22,342,000 21,016,000 21,658,000 20,092,000 18,220,000 15,930,000 14,397,000 13,454,000 12,370,000 10,625,000 
        prepaid expenses and other current assets
      23,322,000 20,310,000 20,584,000 21,294,000 20,308,000 19,886,000 20,478,000 19,578,000 20,666,000 15,841,000 18,758,000 11,798,000 9,357,000 9,718,000 11,045,000 12,085,000 10,313,000 7,109,000 8,108,000 3,433,000 5,439,000 3,321,000 2,651,000 10,646,000 9,880,000 10,649,000 10,904,000 2,167,000 2,030,000 1,530,000 1,778,000 1,986,000 1,767,000 2,019,000 2,114,000 2,451,000 4,262,000 2,941,000 3,559,000 3,854,000 5,052,000 5,225,000 4,203,000 4,734,000 5,466,000 7,230,000 7,886,000 11,168,000 7,694,000 6,069,000 5,619,000 5,753,000 5,953,000 7,344,000 6,020,000 5,901,000 6,888,000 7,145,000 8,831,000 7,795,000 6,652,000 5,851,000 5,744,000 5,057,000 3,128,000 4,468,000 4,038,000 4,418,000 3,847,000 6,594,000 5,130,000 1,752,000 1,968,000 2,469,000 2,352,000 1,923,000 2,234,000 2,325,000 2,279,000 
        total current assets
      450,876,000 439,779,000 443,326,000 434,892,000 417,399,000 362,425,000 376,605,000 405,292,000 451,091,000 333,558,000 299,667,000 299,153,000 255,634,000 268,712,000 265,239,000 303,378,000 331,157,000 357,162,000 206,359,000 279,121,000 184,160,000 86,682,000 95,964,000 91,712,000 108,318,000 117,404,000 75,946,000 63,749,000 75,536,000 78,079,000 86,523,000 90,732,000 66,478,000 60,742,000 64,226,000 72,406,000 72,824,000 75,574,000 93,687,000 100,259,000 101,858,000 100,275,000 100,074,000 102,468,000 113,112,000 112,712,000 117,368,000 135,450,000 113,745,000 112,474,000 113,047,000 119,178,000 122,052,000 121,770,000 115,360,000 112,886,000 116,429,000 119,439,000 121,865,000 126,775,000 122,824,000 133,225,000 132,616,000 105,116,000 67,622,000 69,356,000 75,755,000 65,680,000 65,509,000 57,875,000 55,217,000 65,203,000 63,875,000 71,470,000 40,567,000 40,616,000 45,498,000 46,472,000 54,518,000 
        property and equipment
      135,324,000 138,226,000 139,729,000 146,641,000 156,394,000 171,430,000 180,614,000 171,128,000 149,835,000 133,785,000 119,372,000 109,750,000 101,952,000 98,908,000 99,183,000 96,185,000 87,401,000 77,214,000 66,051,000 56,124,000 36,670,000 27,681,000 24,671,000 20,919,000 19,722,000 18,723,000 15,090,000 12,821,000 13,235,000 12,295,000 12,060,000 11,549,000 12,670,000 13,275,000 14,467,000 15,408,000 15,076,000 13,712,000 21,601,000 22,673,000 21,945,000 23,720,000 23,834,000 25,913,000 26,040,000 26,510,000 27,390,000 28,136,000 28,030,000 29,515,000 30,471,000 31,310,000 30,403,000 31,806,000 31,516,000 32,089,000 31,476,000 34,322,000 34,691,000 35,389,000 38,440,000 39,415,000 40,603,000 36,116,000 30,356,000 29,955,000 28,862,000 27,170,000 23,093,000 21,547,000 17,377,000 13,884,000 12,229,000 12,507,000 12,277,000 11,546,000 12,583,000 11,774,000 11,469,000 
        right-of-use assets
      31,225,000 32,610,000 33,921,000 33,996,000 34,701,000 37,015,000 37,178,000 23,631,000 26,410,000 27,086,000 27,421,000 28,063,000 28,360,000 28,451,000 28,116,000  25,283,000                                                               
        goodwill
      75,208,000 75,199,000 75,218,000 72,334,000 70,976,000 73,397,000 72,008,000 72,249,000 73,003,000 71,555,000 72,527,000 47,924,000 39,775,000 37,593,000 39,170,000 40,831,000 39,689,000 44,335,000 45,189,000 13,897,000 13,897,000 13,897,000 13,897,000 13,897,000 13,897,000 13,897,000 13,897,000 13,897,000 13,897,000 14,469,000 14,250,000 14,346,000           163,752,000 161,702,000 171,333,000 175,089,000 182,301,000 183,088,000 183,004,000 181,390,000 177,832,000 175,669,000 180,838,000 168,499,000 165,144,000 171,386,000 168,609,000 173,626,000 178,905,000 177,260,000 170,194,000 172,318,000 162,098,000 172,631,000 60,113,000 60,132,000 60,087,000 60,068,000 60,124,000 60,129,000 60,128,000 60,183,000 60,003,000 59,465,000 59,501,000 59,501,000 60,389,000 60,509,000 60,897,000 
        intangible assets
      93,454,000 96,043,000 95,593,000 95,040,000 93,518,000 98,785,000 99,152,000 99,814,000 102,451,000 102,196,000 105,508,000 81,079,000 82,781,000 79,738,000 78,611,000 82,090,000 85,274,000 88,840,000 92,981,000 24,129,000              5,482,000 5,243,000 5,477,000  6,152,000 19,756,000 21,004,000                                        
        other assets
      5,121,000 5,391,000 2,506,000 2,570,000 2,722,000 2,843,000 3,029,000 2,467,000 2,418,000 2,041,000 3,739,000 3,724,000 4,874,000 2,881,000 1,616,000 1,544,000 3,249,000 3,910,000 3,786,000 541,000 541,000 549,000 493,000 493,000 493,000 214,000 222,000 277,000 347,000 223,000 225,000 137,000 208,000 222,000 222,000 222,000 516,000 516,000 1,408,000 1,454,000 1,285,000 1,446,000 1,627,000 2,909,000 4,179,000 1,863,000 2,239,000 2,432,000 1,787,000 2,012,000 1,710,000 1,815,000 1,978,000 2,528,000 2,818,000 2,693,000 3,034,000 3,475,000 4,164,000 3,691,000 2,410,000 3,081,000 2,330,000 2,520,000 1,501,000 1,645,000 1,706,000 1,840,000 2,542,000 2,515,000 2,525,000 2,314,000 1,499,000 1,160,000 1,131,000 526,000 622,000 1,552,000 621,000 
        total assets
      791,208,000 787,248,000 790,293,000 785,473,000 775,710,000 745,895,000 768,586,000 774,581,000 805,208,000 670,221,000 628,234,000 569,693,000 513,376,000 516,283,000 511,935,000 548,689,000 572,053,000 598,108,000 441,027,000 404,503,000 261,223,000 154,677,000 161,135,000 153,839,000 169,948,000 178,283,000 133,432,000 119,417,000 129,477,000 131,465,000 139,495,000 143,336,000 84,660,000 79,773,000 84,197,000 93,571,000 94,188,000 96,025,000 136,452,000 145,390,000 146,704,000 148,384,000 314,172,000 320,106,000 344,923,000 348,602,000 364,710,000 386,282,000 365,630,000 366,135,000 366,671,000 374,199,000 382,127,000 365,666,000 357,053,000 364,682,000 366,692,000 372,690,000 384,446,000 388,735,000 377,016,000 390,393,000 374,692,000 357,205,000 161,888,000 164,305,000 169,115,000 158,233,000 155,548,000 147,093,000 141,168,000 150,322,000 147,240,000 156,740,000 126,472,000 124,067,000 129,277,000 131,409,000 139,479,000 
        liabilities and stockholders’ equity
                                                                                     
        current liabilities:
                                                                                     
        accounts payable
      40,893,000 36,875,000 47,240,000 38,751,000 52,984,000 59,578,000 72,739,000 60,358,000 48,985,000 50,104,000 43,698,000 39,070,000 34,742,000 33,374,000 33,157,000 34,036,000 25,737,000 29,438,000 29,812,000 26,416,000 17,599,000 13,910,000 15,955,000 11,800,000 7,772,000 6,010,000 8,178,000 6,780,000 4,399,000 5,642,000 3,354,000 3,769,000 3,878,000 2,865,000 2,861,000 4,245,000 8,701,000 6,821,000 17,447,000 19,293,000 14,169,000 10,827,000 10,422,000 8,909,000 10,130,000 11,333,000 13,965,000 16,462,000 10,790,000 14,171,000 18,329,000 18,516,000 15,237,000 17,529,000 13,956,000 14,431,000 17,390,000 14,987,000 14,919,000 15,868,000 15,957,000 19,272,000 21,242,000 23,073,000 12,781,000 14,049,000 13,809,000 13,965,000 10,504,000 9,958,000 6,854,000 6,382,000 5,948,000 4,931,000 4,929,000 3,144,000 5,798,000 5,256,000 4,103,000 
        accrued expenses and other current liabilities
      97,019,000 102,776,000 87,013,000 98,943,000 81,466,000 76,262,000 75,925,000 87,509,000 87,712,000 77,251,000 74,123,000 69,032,000 72,382,000 61,741,000 55,874,000 61,152,000 55,549,000 43,985,000 43,455,000                                                             
        contract liabilities
      10,439,000 10,069,000 11,497,000 11,300,000 10,467,000 11,602,000 11,775,000 13,632,000 13,910,000 13,833,000 13,895,000 13,938,000 11,956,000 12,293,000 13,850,000                                                                 
        short-term debt
      64,526,000 64,663,000 1,929,000 2,569,000 1,656,000 1,790,000 2,289,000 2,548,000 1,808,000 1,766,000 2,207,000 16,068,000 14,948,000 13,550,000 14,266,000 1,789,000 342,000 6,119,000 10,988,000                                                             
        current portion of operating lease liabilities
      6,298,000 6,442,000 6,505,000 6,310,000 6,453,000 6,989,000 6,723,000 5,239,000 5,159,000 5,090,000 4,824,000 4,796,000 4,842,000 4,529,000 4,164,000                                                                 
        total current liabilities
      219,175,000 220,825,000 154,184,000 157,873,000 153,026,000 156,221,000 169,451,000 169,286,000 157,574,000 148,044,000 138,747,000 142,904,000 138,870,000 125,487,000 121,311,000 115,904,000 101,095,000 100,071,000 107,565,000 70,149,000 58,312,000 48,165,000 42,795,000 38,243,000 36,390,000 31,585,000 31,006,000 27,627,000 30,612,000 33,144,000 35,028,000 34,495,000 29,742,000 28,791,000 29,575,000 33,327,000 40,135,000 42,380,000 125,226,000 129,565,000 125,400,000 98,579,000 53,308,000 56,713,000 63,601,000 66,172,000 69,789,000 94,399,000 79,719,000 56,371,000 49,811,000 55,503,000 56,788,000 53,204,000 50,155,000 49,567,000 57,137,000 44,111,000 42,529,000 45,472,000 43,591,000 58,016,000 55,208,000 61,033,000 38,079,000 38,763,000 43,280,000 37,790,000 31,210,000 44,814,000 34,497,000 40,630,000 24,073,000 21,085,000 20,139,000 18,006,000 21,390,000 17,979,000 18,033,000 
        long-term debt
      501,412,000 495,017,000 551,988,000 545,834,000 574,522,000 525,935,000 516,881,000 511,889,000 511,035,000 506,613,000 455,341,000 419,455,000 349,511,000 348,324,000 313,397,000 326,639,000 326,489,000 320,974,000 55,789,000                                                             
        operating lease liabilities, less current portion
      23,856,000 25,031,000 26,207,000 26,562,000 27,305,000 29,140,000 29,626,000 21,069,000 23,677,000 24,496,000 25,287,000 25,907,000 26,562,000 26,952,000 27,335,000                                                                 
        other long-term liabilities
      10,736,000 11,266,000 10,540,000 10,878,000 11,423,000 12,358,000 11,914,000 11,182,000 11,203,000 11,626,000 13,409,000 16,186,000 11,543,000 14,486,000 15,750,000 16,625,000 17,061,000 16,752,000 15,143,000 11,289,000 11,353,000 9,038,000 9,651,000 10,971,000 11,951,000 13,082,000 13,826,000 14,600,000 15,389,000 16,220,000 16,978,000 19,000,000 20,206,000 23,666,000 24,391,000 25,757,000 28,862,000 29,951,000 33,800,000 34,251,000 33,797,000 29,814,000 30,599,000 31,261,000 32,220,000 32,965,000 34,360,000 36,039,000 38,784,000 11,130,000 11,988,000 12,556,000 13,485,000 11,130,000 11,593,000 11,679,000 12,997,000 1,826,000 2,892,000 2,751,000 2,153,000 4,525,000 2,565,000 3,013,000 1,008,000 1,963,000 1,747,000 2,033,000 1,889,000 1,749,000 1,675,000 1,518,000 1,478,000 1,421,000 1,342,000 1,743,000 1,886,000 1,344,000 1,581,000 
        redeemable preferred stock, 0.0001 par value...
      23,603,000 23,603,000 23,603,000 23,603,000 23,603,000 23,603,000 23,603,000 23,603,000 23,603,000 23,603,000 23,603,000 23,603,000 23,603,000 23,603,000 23,603,000 23,603,000 23,603,000 23,603,000 23,603,000 23,603,000 23,603,000 23,603,000 23,603,000 23,603,000 23,603,000 23,603,000 23,603,000 23,603,000 23,603,000 23,603,000 23,603,000 23,603,000 23,603,000 23,603,000 23,603,000 23,603,000 23,603,000 23,603,000 23,603,000 23,603,000 23,603,000 23,603,000 23,603,000 23,603,000 23,603,000 23,603,000 23,603,000 23,603,000 23,603,000 23,603,000 23,603,000 23,603,000 23,603,000 23,603,000 23,603,000 23,603,000 23,603,000 23,603,000 23,603,000 23,603,000 23,603,000 23,603,000 23,603,000 23,603,000 23,603,000 23,605,000 23,605,000 23,605,000 23,605,000 23,606,000 23,606,000         
        commitments and contingencies
                                                                                     
        stockholders’ equity
                                                                                     
        common stock, 0.0001 par value...
      15,000 15,000 15,000 15,000 14,000 14,000 14,000 14,000 14,000 12,000 12,000 12,000 11,000 11,000 11,000 10,000 10,000 10,000 10,000 8,000 8,000 6,000 6,000 6,000 6,000 6,000 4,000 4,000 4,000 4,000 4,000 2,000 2,000 2,000 1,000 1,000 1,000 1,000 10,000 10,000 10,000 10,000 10,000 10,000 10,000 10,000 10,000 10,000 10,000 10,000 10,000 10,000 10,000 9,000 9,000 9,000 9,000 9,000 9,000 9,000 9,000 9,000 9,000 8,000 5,000 5,000 5,000 5,000 5,000 5,000 5,000 5,000 5,000 5,000 3,000 3,000 3,000 3,000  
        treasury stock
      -25,097,000 -25,097,000 -25,097,000 -25,097,000 -25,097,000 -25,097,000 -25,097,000 -25,097,000 -25,097,000 -25,097,000 -25,097,000 -25,097,000 -25,097,000 -25,097,000 -25,097,000 -25,097,000 -25,097,000 -25,097,000 -97,000 -97,000 -97,000 -97,000 -97,000 -97,000 -97,000 -97,000 -97,000 -97,000 -97,000 -97,000 -97,000 -97,000 -97,000 -97,000 -97,000 -97,000 -97,000 -97,000 -97,000 -97,000 -97,000 -97,000 -97,000 -97,000 -97,000 -97,000 -97,000 -97,000 -97,000 -97,000 -97,000 -97,000 -97,000 -97,000 -97,000 -97,000 -97,000 -97,000 -97,000 -97,000 -97,000 -97,000 -97,000 -97,000      -60,000          
        additional paid-in capital
      1,466,377,000 1,443,648,000 1,427,244,000 1,282,598,000 1,305,677,000 1,279,886,000 1,261,860,000 1,240,879,000 1,230,484,000 1,062,919,000 1,033,673,000 952,265,000 933,537,000 919,319,000 910,577,000 899,414,000 892,828,000 883,296,000 914,659,000 774,031,000 770,764,000 623,162,000 618,282,000 611,091,000 606,558,000 603,518,000 545,423,000 528,094,000 523,525,000 506,078,000 502,683,000 496,972,000 436,803,000 438,969,000 438,005,000 437,483,000 419,787,000 418,927,000 417,360,000 416,997,000 416,939,000 416,620,000 416,720,000 415,167,000 413,921,000 412,636,000 411,032,000 404,514,000 403,568,000 402,250,000 401,389,000 400,427,000 399,246,000 388,546,000 387,551,000 386,786,000 386,224,000 385,601,000 385,172,000 384,313,000 383,647,000 380,263,000 379,048,000 335,178,000 175,021,000 174,020,000 170,671,000 159,023,000 158,140,000 156,847,000 156,079,000 154,473,000 153,394,000 152,970,000 118,134,000 113,814,000 113,563,000 116,453,000 115,288,000 
        accumulated other comprehensive loss
      -4,426,000 -4,346,000 -4,255,000 -10,463,000 -13,678,000 -8,412,000 -11,529,000 -10,787,000 -8,323,000 -12,111,000 -9,511,000                            -19,547,000 -20,396,000 -21,188,000 -20,350,000 -20,974,000 -22,513,000    4,056,000      -2,307,000 -7,132,000  -2,812,000                       
        accumulated deficit
      -1,424,443,000 -1,402,714,000 -1,374,136,000 -1,332,992,000 -1,281,085,000 -1,247,753,000 -1,208,137,000 -1,167,457,000 -1,118,962,000 -1,069,884,000 -1,027,230,000 -975,853,000 -934,474,000 -899,488,000 -862,489,000 -825,169,000 -782,325,000 -742,138,000 -699,107,000 -660,902,000 -637,999,000 -611,201,000 -595,532,000 -579,727,000 -558,924,000 -541,893,000 -527,326,000 -514,890,000 -501,922,000 -477,806,000 -468,451,000 -461,375,000 -459,459,000 -468,514,000 -465,377,000 -462,680,000 -457,165,000 -452,811,000 -439,090,000 -433,857,000 -427,240,000 -417,337,000 -257,072,000 -253,123,000 -248,564,000 -248,291,000 -245,250,000 -242,355,000 -235,682,000 -175,275,000 -160,765,000 -156,104,000 -153,455,000 -148,100,000 -145,631,000 -139,257,000 -137,996,000 -122,030,000 -120,726,000 -117,682,000 -115,815,000 -112,939,000 -109,149,000 -106,170,000 -101,460,000 -100,140,000 -98,857,000 -92,554,000 -88,171,000 -83,113,000 -78,253,000 -74,662,000 -58,883,000 -47,636,000 -42,058,000 -41,355,000 -36,681,000 -34,377,000  
        total stockholders’ equity
      12,426,000 11,506,000 23,771,000    17,111,000 37,552,000 78,116,000      10,539,000 41,984,000 79,422,000 111,757,000 213,514,000 108,292,000 129,880,000 8,051,000 18,822,000 27,430,000 43,631,000 57,654,000 14,161,000 9,250,000 17,574,000 24,213,000 30,220,000 31,573,000           133,587,000 134,444,000 148,954,000 153,320,000 163,850,000 166,128,000 171,676,000 228,970,000 237,882,000 239,863,000 245,816,000 238,051,000 234,700,000 248,875,000 245,328,000 267,469,000 275,324,000 275,096,000 266,434,000 269,583,000 257,993,000 230,549,000 74,829,000 75,252,000 72,942,000 67,530,000 71,469,000 74,317,000 78,477,000 81,930,000 94,850,000 105,603,000 75,961,000 73,657,000 74,996,000 82,223,000 86,405,000 
        total liabilities and stockholders’ equity
      791,208,000 787,248,000 790,293,000   745,895,000 768,586,000 774,581,000 805,208,000      511,935,000 548,689,000 572,053,000 598,108,000 441,027,000 404,503,000 261,223,000 154,677,000 161,135,000 153,839,000 169,948,000 178,283,000 133,432,000 119,417,000 129,477,000 131,465,000 139,495,000 143,336,000           314,172,000 320,106,000 344,923,000 348,602,000 364,710,000 386,282,000 365,630,000 366,135,000 366,671,000 374,199,000 382,127,000 365,666,000 357,053,000 364,682,000 366,692,000 372,690,000 384,446,000 388,735,000 377,016,000 390,393,000 374,692,000 357,205,000 161,888,000 164,305,000 169,115,000 158,233,000 155,548,000 147,093,000 141,168,000 150,322,000 147,240,000 156,740,000 126,472,000 124,067,000 129,277,000 131,409,000 139,479,000 
        stockholders' equity
                                                                                     
        liabilities and stockholders’ deficit
                                                                                     
        derivative liability
         106,662,000                                                                            
        stockholders' deficit:
                                                                                     
        total stockholders’ deficit
         -85,939,000      -44,161,000 -28,153,000 -58,362,000                     -26,658,000 -33,515,000 -31,550,000 -29,133,000 -41,504,000 -38,211,000 -46,364,000 -42,343,000                                        
        total liabilities and stockholders’ deficit
         785,473,000      670,221,000 628,234,000 569,693,000                     84,660,000 79,773,000 84,197,000 93,571,000 94,188,000 96,025,000 136,452,000 145,390,000                                        
        liabilities and stockholders’ (deficit) equity
                                                                                     
        stockholders’ (deficit) equity:
                                                                                     
        total stockholders’ (deficit) equity
          -14,169,000 -1,362,000       -36,713,000 -22,569,000                           -36,576,000 -26,154,000                                      
        total liabilities and stockholders’ (deficit) equity
          775,710,000        513,376,000 516,283,000                           146,704,000 148,384,000                                      
        revenue from products and services
          611,562,000        350,852,000 89,839,000                                                                  
        cost of sales
          187,300,000        117,808,000 30,323,000                                                                  
        gross profit
          424,262,000        233,059,000 59,516,000                            28,479,000                                      
        operating expenses:
                                                                                     
        research and development
          80,718,000        44,033,000 12,111,000                            1,898,000                                      
        sales, general and administrative
          450,199,000        300,013,000 75,954,000                                                                  
        litigation-related expenses
          9,799,000        23,943,000 3,602,000                                                                  
        amortization expense
          16,258,000                                                                           
        transaction-related expenses
          210,000        120,000                                                                   
        restructuring expenses
          3,247,000        1,810,000 45,000                            335,000                                      
        total operating expenses
          560,431,000        380,034,000 94,486,000                            193,427,000                                      
        operating income
          -136,169,000        -146,975,000 -34,970,000                            -164,948,000                                      
        other income, net:
                                                                                     
        interest expense
          -24,879,000        -5,505,000 -1,285,000                            -3,110,000                                      
        other income
          -1,025,000        471,000 -615,000                            6,058,000                                      
        total other income
          -25,904,000                                     2,966,000                                      
        net income before taxes
          -162,073,000        -152,009,000 -36,870,000                                                                  
        income tax benefit
          50,000                                     -1,717,000                                      
        net income
          -162,123,000        -152,149,000 -36,999,000                            -160,265,000                                      
        net income per share
          -1,130        -1,470 -350                                                                  
        weighted-average shares outstanding, basic and diluted
          142,946,000        103,373,000 104,804,000                                                                  
        stockholders' (deficit) equity:
                                                                                     
        stockholders' equity:
                                                                                     
        series a convertible preferred stock, 0.0001 par value...
                                                                                     
        accumulated other comprehensive deficit
                 -9,689,000 -10,690,000 -17,314,000 -12,463,000 -7,174,000                                                                
        revenue:
                                                                                     
        revenue from international supply agreement
                  15,000                                                                   
        total revenue
                  350,867,000 89,839,000                                                                  
        amortization of acquired intangible assets
                  10,115,000 2,774,000                            363,000                                      
        interest and other income, net:
                                                                                     
        loss on debt extinguishment
                                                                                     
        total interest and other income
                  -5,034,000 -1,900,000                                                                  
        income tax provision
                  140,000 129,000                                                                  
        right-of-use asset
                     24,661,000  26,647,000 26,604,000 21,704,000 1,177,000 1,530,000 1,333,000 1,601,000 1,860,000                                                       
        contract liability
                     14,893,000 15,255,000 16,670,000 20,392,000                                                             
        current portion of operating lease liability
                     4,034,000 4,212,000 3,859,000 2,777,000 1,486,000 885,000 1,208,000 1,404,000   1,263,000 1,173,000 1,132,000                                                    
        operating lease liability, less current portion
                     23,934,000 24,383,000 24,951,000 25,413,000 20,752,000 41,000 56,000 191,000 559,000 925,000                                                       
        withholding tax receivable from officer
                        1,076,000 1,076,000 1,076,000 934,000 577,000   203,000   350,000                                                   
        current assets of discontinued operations
                        136,000 348,000 352,000 335,000 322,000 353,000 321,000 214,000 225,000 237,000 242,000 246,000 251,000 269,000 131,000 236,000 69,000 170,000 364,000 2,828,000                                          
        noncurrent assets of discontinued operations
                        57,000 55,000 58,000 55,000 53,000 52,000 53,000 51,000 53,000 53,000 54,000 54,000 55,000 58,000 56,000 52,000 39,000 58,000 61,000 71,000                                          
        current liabilities of discontinued operations
                        141,000 143,000 397,000 395,000 400,000 399,000 399,000 504,000 538,000 569,000 621,000 419,000 385,000 467,000 312,000 283,000 464,000 293,000 732,000 2,207,000                                          
        stockholders’ equity:
                                                                                     
        shareholder note receivable
                       -700,000 -1,800,000 -2,900,000 -4,000,000 -5,000,000 -5,000,000 -5,000,000 -5,000,000 -5,000,000 -5,000,000 -5,000,000 -5,000,000 -5,000,000 -5,000,000 -5,000,000 -5,000,000 -5,000,000 -5,000,000 -5,000,000 -5,000,000 -5,000,000 -5,000,000 -5,000,000 -5,000,000 -5,000,000 -5,000,000 -5,000,000 -5,000,000 -5,000,000 -5,000,000                                 
        accumulated other comprehensive (deficit) income
                      -5,994,000                                                               
        cash
                       223,868,000 76,581,000 191,137,000 107,765,000 15,678,000 31,163,000 27,466,000 47,113,000 57,843,000 18,570,000 16,419,000 29,054,000 35,111,000 44,912,000 47,645,000 22,466,000 15,437,000 19,107,000 25,485,000 19,593,000 25,598,000 9,322,000 7,761,000 11,229,000 10,502,000 8,898,000 11,400,000 19,735,000 20,169,000 18,983,000 23,764,000 21,345,000                               
        accumulated other comprehensive income
                       -3,614,000 -151,000 -1,848,000 1,204,000 1,181,000 1,163,000 1,157,000 1,088,000 1,120,000 1,157,000 1,139,000 1,064,000 1,034,000 1,081,000 1,071,000 1,093,000 1,125,000 918,000 1,160,000 970,000 769,000       -11,316,000 -5,938,000 3,155,000  3,877,000 2,082,000 -2,655,000 -4,373,000 112,000   1,434,000  3,986,000 10,966,000 8,553,000 -1,310,000 1,807,000 -12,311,000 1,092,000 1,263,000 1,367,000 1,123,000 1,056,000 1,495,000 638,000 646,000 1,103,000 334,000 264,000 -118,000 76,000 111,000 144,000 53,000 
        debt securities
                         1,313,000                                                            
        equity securities
                         7,619,000                                                            
        accrued expenses
                         36,730,000 35,231,000 30,980,000 24,637,000 23,772,000 26,416,000 22,972,000 20,831,000 18,527,000 22,316,000 20,897,000 24,607,000 23,368,000 22,246,000 22,606,000 23,917,000 26,173,000 27,589,000 30,705,000 30,459,000 30,858,000 29,791,000 27,216,000 28,147,000 30,380,000 35,393,000 34,995,000 36,904,000 62,454,000 62,996,000 35,952,000 29,597,000 34,397,000 38,490,000 30,886,000 32,782,000 28,359,000 32,583,000 23,229,000 23,356,000 24,985,000 22,530,000 24,580,000 21,464,000 23,423,000 16,439,000 16,242,000 22,167,000 18,287,000 16,739,000 16,045,000 14,144,000 9,576,000 13,368,000 10,981,000 9,923,000 10,006,000 10,369,000 8,694,000 9,740,000 
        current portion of long-term debt
                         5,374,000 4,200,000 1,672,000 399,000 916,000 489,000 836,000 286,000 619,000 3,276,000 6,186,000 6,682,000 6,891,000 3,306,000 3,037,000 2,333,000 2,616,000 3,113,000 2,647,000 75,376,000 78,105,000 80,105,000 59,018,000 6,753,000 7,256,000 8,076,000 8,042,000 5,909,000 4,189,000 4,924,000 4,984,000 709,000 1,277,000 1,700,000 1,720,000 766,000 3,653,000 4,396,000 2,544,000 963,000 1,353,000 1,708,000 10,147,000 10,024,000 10,055,000 6,724,000 6,405,000 4,439,000 3,037,000 2,109,000 3,199,000 3,104,000 2,084,000 2,211,000 2,475,000 2,773,000 2,227,000 2,060,000 2,333,000 2,471,000 
        long-term debt, less current portion
                         38,580,000 38,034,000 65,764,000 66,073,000 53,033,000 53,448,000 51,094,000 49,369,000 42,559,000 42,299,000 34,285,000 33,666,000 34,665,000 37,767,000 37,228,000 38,178,000 40,017,000 43,092,000 38,215,000 187,000 314,000 480,000 20,919,000 69,784,000 72,223,000 74,597,000 70,617,000 70,909,000 64,115,000 49,978,000 43,784,000 41,118,000 40,578,000 39,967,000 36,031,000 35,307,000 26,649,000 23,802,000 28,771,000 32,223,000 32,330,000 32,474,000 22,680,000 24,165,000 26,752,000 23,631,000 23,724,000 26,577,000 26,360,000 26,488,000 1,500,000 1,515,000 1,568,000 1,954,000 2,410,000 2,887,000 2,630,000 3,111,000 2,882,000 3,333,000 
        contingently redeemable common stock, 0.0001 par value...
                         131,838,000                                                            
        intangibles assets
                          24,720,000 24,283,000                                                          
        series b convertible preferred stock, 0.0001 par value...
                                                                                     
        intangibles
                            24,724,000 25,165,000 25,605,000 25,882,000 26,054,000 26,226,000 26,408,000 26,345,000 26,382,000 26,514,000 5,248,000    5,711,000    21,616,000 22,943,000 24,885,000 27,114,000 30,259,000 32,428,000 35,412,000 37,176,000 39,064,000 40,744,000 43,611,000 46,227,000 46,856,000 41,063,000 42,215,000 45,628,000 47,144,000 41,828,000 44,821,000 45,620,000 43,148,000 42,354,000 37,045,000 40,822,000 2,296,000 3,217,000 2,705,000 3,475,000 4,280,000 5,027,000 5,921,000 8,738,000 9,634,000 12,138,000 12,996,000 11,878,000 10,185,000 11,102,000 11,974,000 
        current portion of lease liability
                             1,356,000 1,314,000                                                       
        operating lease right-of-use asset
                               2,112,000 2,170,000 2,394,000                                                    
        operating lease liability
                               1,265,000 1,467,000 1,778,000                                                    
        stockholders’ deficit:
                                                                                     
        restricted cash
                                            150,000 1,250,000 2,350,000 3,450,000 4,400,000 4,400,000 4,400,000 2,001,000 2,001,000 17,750,000                         2,000,000 3,100,000 3,100,000 3,100,000 1,100,000   
        common stock warrant liabilities
                                            1,145,000 573,000 687,000 687,000 6,985,000 8,817,000 8,702,000 10,660,000 11,173,000 10,250,000                                
        long-term liabilities of discontinued operations
                                                                                     
        long term liabilities of discontinued operations
                                           87,000                                          
        deferred revenue
                                            799,000 736,000 648,000 831,000 1,001,000 1,351,000 1,300,000 1,142,000 1,838,000 1,044,000 1,009,000 1,264,000 1,176,000 1,313,000 1,361,000 3,069,000 2,651,000 3,124,000 2,768,000 3,351,000 3,291,000 3,266,000 3,396,000 2,984,000 1,299,000 1,618,000 2,135,000 2,067,000 2,865,000 2,501,000 1,858,000 2,862,000 1,085,000         
        deferred income tax assets
                                               2,518,000 2,479,000 1,248,000 1,324,000 1,273,000 1,389,000 1,388,000 1,372,000 2,874,000 2,835,000 2,964,000 2,991,000 2,576,000 1,105,000 1,401,000 1,248,000 1,592,000 1,588,000 1,594,000 1,592,000 1,817,000 1,398,000 1,427,000 128,000 419,000 413,000 411,000 418,000          3,057,000 
        deferred income tax liabilities
                                               1,623,000 3,291,000 1,862,000 1,948,000 1,925,000 2,199,000 1,998,000 1,870,000 2,277,000 2,269,000 2,096,000 2,468,000 3,647,000 1,695,000 4,309,000 3,825,000 6,910,000 7,875,000 9,483,000 8,761,000 11,986,000 11,158,000 12,255,000 738,000 998,000 964,000 915,000 887,000 1,107,000 1,098,000 1,068,000 1,273,000 2,539,000 2,440,000 1,513,000 1,467,000  3,057,000 
        revenues
                                               42,996,000                                      
        cost of revenues
                                               14,154,000                                      
        in-process research and development
                                               274,000                                      
        sales and marketing
                                               17,134,000                                      
        general and administrative
                                               8,094,000                                      
        goodwill and intangible impairment
                                               165,171,000                                      
        other income:
                                                                                     
        interest income
                                               18,000                                      
        pretax net income
                                               -161,982,000                                      
        net income per basic share
                                               -1,610                                      
        net income per diluted share
                                               -1,610                                      
        shares used in calculating basic net income per share
                                               99,376,000                                      
        shares used in calculating diluted net income per share
                                               99,376,000                                      
        other current liabilities
                                                                   1,033,000 1,179,000 2,864,000                
        total alphatec stockholders’ equity
                                                                   269,043,000 257,500,000 230,011,000                
        non-controlling interest
                                                                   540,000 493,000 538,000                
        lines of credit
                                                                             9,366,000 2,546,000 2,698,000 2,514,000 2,629,000 3,163,000 1,696,000 1,719,000 
        deferred income tax asset
                                                                           674,000 700,000 706,000 937,000 1,213,000 1,212,000 1,203,000 1,184,000   
        line of credit
                                                                           12,750,000 9,310,000         
        deferred revenue, less current portion
                                                                            300,000         
        accrued litigation
                                                                             13,222,000        
        new redeemable preferred stock, 0.0001 par value...
                                                                             23,608,000 23,612,000 23,682,000 23,703,000 23,703,000 23,703,000 23,703,000 23,703,000 
        stock subscription
                                                                             1,011,000    1,119,000    
        minority interest
                                                                                 2,815,000 2,724,000 3,288,000 3,377,000 
        current portion of note payable to related party
                                                                                     
        note payable to related party, less current portion
                                                                                     
        redeemable convertible preferred, rolling common and series c common stock, 0.0001 par value...
                                                                                     
        deferred compensation
                                                                                     
        stockholder notes receivable
                                                                                   -10,000  
        common stock, .0001 par value...
                                                                                    3,000 
      Cashflow Statements:
      Quarterly
      Annual
        Unit: USD2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31 2009-12-31 2009-09-30 2009-06-30 2009-03-31 2008-12-31 2008-09-30 2008-06-30 2008-03-31 2007-12-31 2007-09-30 2007-06-30 2007-03-31 2006-12-31 2006-09-30 
                                                                                       
          operating activities:
                                                                                       
          net loss
        -33,906,000 -21,729,000 -28,578,000 -41,144,000 -51,907,000 -33,332,000 -39,616,000 -40,680,000 -48,495,000 -49,078,000 -42,654,000 -51,377,000 -43,529,000 -34,986,000 -36,999,000 -37,320,000 -42,844,000 -40,187,000 -43,031,000 -38,205,000 -22,903,000   -15,805,000 -20,722,000    -12,968,000  -9,355,000 -7,076,000 -1,916,000  -3,137,000   -4,354,000   -6,617,000       -2,895,000 -6,673,000 -60,407,000        -15,966,000 -1,304,000 -3,044,000 -1,867,000 -2,876,000 -3,790,000 -2,979,000 -4,710,000 -1,320,000 -1,283,000 -6,303,000 -4,383,000 -5,058,000 -4,860,000 -3,591,000 -15,779,000 -11,247,000 -5,578,000 -703,000 -2,674,000  -5,438,000 
          adjustments to reconcile net loss to net cash from operating activities:
                                                                                       
          depreciation and amortization
        19,135,000 19,101,000 19,156,000 19,328,000 19,907,000 20,008,000 20,648,000 19,877,000 17,885,000 16,019,000 14,745,000 13,683,000 11,692,000 11,349,000 10,812,000 9,692,000 9,315,000 8,770,000 7,592,000 6,544,000 3,850,000 3,145,000 2,748,000 2,602,000 2,454,000 2,224,000 1,924,000 1,645,000 1,785,000 1,723,000 1,591,000 1,589,000 1,886,000 1,945,000 1,798,000 1,870,000 1,868,000 1,961,000 3,022,000 3,497,000 3,884,000 4,932,000 4,512,000 5,425,000 4,162,000 4,379,000 4,451,000 4,704,000 4,851,000 6,313,000 7,375,000 6,330,000 6,259,000 6,369,000 5,800,000 5,820,000 5,803,000 4,937,000 4,957,000 4,979,000 5,003,000 4,795,000 4,614,000 4,275,000 3,562,000 3,312,000 3,146,000 2,897,000 2,601,000 2,816,000 2,242,000 1,638,000 2,035,000 2,793,000 2,742,000 2,527,000 2,410,000 2,609,000 1,979,000 
          stock-based compensation
        23,659,000 19,398,000 16,379,000 15,624,000 22,318,000 21,533,000 17,462,000 16,960,000 17,322,000 20,515,000 20,073,000 24,194,000 16,462,000 10,092,000 11,077,000 9,203,000 10,184,000 9,726,000 10,754,000 11,496,000 4,474,000 4,972,000 4,544,000 4,575,000 3,568,000 3,390,000 3,603,000 2,351,000 1,612,000 1,862,000 1,675,000 1,148,000 619,000 2,233,000 709,000 444,000 516,000 116,000 1,147,000 305,000 58,000 203,000 -78,000 1,265,000 1,253,000 913,000 1,502,000 1,195,000 944,000 1,246,000 853,000 795,000 1,184,000 1,480,000 1,000,000 663,000 547,000 497,000 480,000 734,000 714,000 851,000 573,000 772,000 981,000 1,008,000 1,098,000 831,000 634,000 672,000 823,000 671,000 769,000 600,000 236,000 -773,000 251,000 4,139,000 1,164,000 
          amortization of debt discount and debt issuance costs
        6,768,000 6,886,000 6,703,000 6,505,000 2,418,000 1,183,000 1,160,000 1,061,000 1,058,000 1,048,000 876,000 1,013,000 697,000 568,000 497,000 484,000 489,000   652,000 640,000 841,000 757,000 1,138,000 1,238,000 1,377,000 1,299,000 530,000 503,000 516,000 481,000 501,000 589,000                                               
          amortization of right-of-use assets
        1,321,000 1,384,000 1,222,000 1,194,000 1,271,000 1,403,000 1,274,000 1,194,000 1,031,000 945,000 909,000 858,000 831,000 833,000 799,000 565,000 563,000 688,000 780,000 928,000 1,022,000                                                           
          write-down for excess and obsolete inventories
        3,616,000 2,212,000 3,379,000 4,373,000 3,571,000 4,451,000 4,113,000 3,878,000 2,979,000 4,420,000 2,454,000 4,636,000 2,098,000 2,769,000 2,923,000 2,394,000 1,706,000                                                               
          loss on disposal of assets
        196,000 177,000 595,000 137,000 1,563,000 -190,000 1,111,000 1,319,000 832,000 1,499,000 807,000 686,000 716,000 855,000 545,000 720,000 474,000                                                               
          loss on debt extinguishment
         17,576,000                                                                           
          gain on derivative liability
         16,780,000 -17,400,000                                                                           
          other
        1,127,000 2,785,000 1,455,000 -104,000 4,252,000 201,000 5,000 3,333,000 1,655,000 -1,262,000 857,000 270,000 590,000 614,000 699,000 117,000 -243,000 1,860,000 -1,130,000                                  285,000    242,000             22,000       
          changes in operating assets and liabilities:
                                                                                       
          accounts receivable
        -10,238,000 -3,374,000 -2,256,000 -5,967,000 -10,282,000 -5,110,000 5,814,000 1,765,000 -17,058,000 -7,857,000 -5,036,000 2,576,000 -2,478,000 -8,699,000 -7,878,000 -3,929,000 1,674,000 -8,724,000 -156,000 630,000 -1,891,000 715,000 -4,542,000 -4,439,000 782,000 -772,000 -1,856,000 62,000 1,268,000 -2,923,000 -819,000 500,000 2,846,000 -1,201,000 -104,000 1,102,000 4,356,000 -2,658,000 7,725,000 3,530,000 -597,000 -2,278,000 2,609,000 -397,000 1,263,000 -1,401,000 3,047,000 -5,234,000 2,560,000 -236,000 -394,000 -636,000 -674,000 -2,986,000 1,733,000 950,000 685,000 -3,085,000 1,245,000 -399,000 -2,765,000 2,966,000 -4,870,000 505,000 -780,000 -3,159,000 2,379,000 113,000 -5,381,000 -1,040,000 -2,094,000 -1,420,000 -719,000 192,000 -907,000 541,000 -1,295,000 -186,000  
          inventories
        -20,570,000 -4,804,000 -594,000 -2,158,000 1,243,000 2,384,000 -14,187,000 -23,343,000 -19,514,000 -9,475,000 -14,041,000 -13,506,000 -8,540,000 -573,000 -3,516,000 -7,461,000 -9,154,000 -3,929,000 -8,622,000 -1,724,000 -13,471,000 -5,472,000 -2,673,000 -5,306,000 -4,741,000 -3,961,000 -2,788,000 -3,565,000 -4,398,000 -2,907,000 -212,000 -172,000 -2,733,000 1,552,000 -677,000 -363,000 -254,000 -1,019,000 -4,645,000 2,970,000 -3,048,000 -3,254,000 -886,000 -630,000 -686,000 -1,214,000 -1,309,000 -586,000 -1,239,000 313,000 359,000 -1,692,000 -3,387,000 -2,178,000 -1,748,000 -1,365,000 -2,562,000 1,224,000 -3,089,000 4,037,000 -1,088,000 -1,364,000 -4,512,000 -5,358,000 -3,427,000 -1,873,000 -1,189,000 -1,023,000 -3,189,000 -2,768,000 -1,759,000 -328,000 -1,731,000 -2,972,000 -1,980,000 -1,535,000 -891,000 -993,000  
          prepaid expenses and other current assets
        -12,000 -2,465,000 287,000 1,230,000 -807,000 -780,000 802,000 -931,000 812,000 -4,599,000 2,772,000 -6,962,000 -2,309,000 533,000 1,112,000 755,000 -1,848,000 -3,557,000 3,300,000 148,000 1,367,000 -644,000 -1,225,000 -78,000 -983,000 -77,000 -22,000 87,000 198,000 -857,000 540,000 266,000 -217,000 335,000 134,000 653,000 1,958,000 -723,000 505,000 403,000 889,000 601,000 796,000 740,000 335,000 720,000 1,503,000 2,712,000 -72,000 -1,177,000 1,080,000 153,000 394,000 487,000 48,000 -289,000 1,435,000 867,000 233,000 -423,000 664,000 -464,000 -284,000 -950,000 -432,000 1,074,000 579,000 678,000 -629,000 1,936,000 -2,762,000 -799,000 493,000 520,000 -38,000 -306,000 308,000 12,000  
          other assets
        -138,000 213,000 40,000 45,000 107,000 207,000 112,000 -644,000 -141,000 -489,000 -7,000 -85,000 40,000 731,000 -587,000 -134,000 -119,000 -58,000 -76,000   2,000    135,000 1,000 57,000 69,000 -42,000 7,000 -92,000 37,000 51,000 -20,000 26,000 291,000 29,000 182,000 -20,000 -21,000 -69,000 81,000 3,000 -74,000 -35,000 -39,000 -128,000 7,000 -45,000 63,000 39,000 278,000 163,000 43,000 508,000 388,000 641,000 115,000 72,000 411,000 212,000 242,000 -186,000 -44,000 14,000 196,000 229,000 13,000 -104,000 -426,000 -400,000 -318,000 14,000 -67,000 12,000 926,000 -937,000 
          accounts payable
        201,000 5,182,000 -14,688,000 10,268,000 -11,918,000 -6,345,000 -6,146,000 15,382,000 6,780,000 -3,301,000 -34,000 4,504,000 5,820,000 2,359,000 -214,000 14,000 7,637,000 1,055,000 -4,095,000 1,637,000 2,160,000 2,884,000 -1,637,000 2,469,000 3,414,000 2,462,000 -781,000 1,003,000 3,319,000 -906,000 1,542,000 -428,000 -192,000 1,005,000 -51,000 1,887,000 -5,433,000 382,000 -8,324,000 173,000 2,904,000 3,486,000 -1,934,000 2,144,000 -487,000 -781,000 -2,406,000 -1,891,000 4,036,000 -1,932,000 -4,091,000 1,273,000 897,000 -1,961,000 3,511,000 -266,000 -3,083,000 1,550,000 2,280,000 -1,682,000 397,000 -3,819,000 1,905,000 -2,882,000 -407,000 -1,970,000 -142,000 -217,000 504,000 615,000 492,000 614,000 190,000 984,000 -99,000 1,528,000 -2,666,000 561,000  
          accrued expenses
        11,203,000 -3,490,000 14,637,000 -9,261,000 13,938,000  2,474,000 -8,125,000 -2,551,000  3,623,000 5,066,000 -705,000  7,790,000                                                                 
          lease liabilities
        -1,249,000 -1,319,000 -1,155,000 -1,067,000 -1,349,000 -1,867,000 -1,189,000 -1,392,000 -1,047,000 -925,000 -1,107,000 -807,000 -763,000 -773,000 -851,000                                                                 
          contract liabilities
        57,000 349,000 -1,404,000 23,000 761,000 -953,000 -291,000 -1,833,000 -184,000 -113,000 67,000 -44,000 1,883,000 -1,147,000 -946,000                                                                 
          other long-term liabilities
        121,000 176,000 -1,138,000 -258,000 -301,000 1,309,000 1,112,000 785,000 198,000 -1,367,000 -1,589,000 -2,577,000 -829,000 -2,292,000 47,000 619,000 -716,000 601,000 3,337,000 519,000 395,000 1,975,000 -1,101,000 -1,701,000 -1,099,000 -1,101,000 -1,097,000 -1,100,000 -1,099,000 -1,100,000 -1,099,000 -1,097,000 -1,071,000                                               
          net cash from operating activities
        1,291,000 20,682,000 14,040,000 15,548,000 -5,039,000 10,523,000 -5,342,000 -11,394,000 -38,438,000 -25,004,000 -17,285,000 -17,872,000 -18,324,000 -8,403,000 -14,690,000 -27,338,000 -24,712,000 -14,856,000 -23,466,000 -16,506,000 -18,604,000 -6,728,000 -9,539,000 -13,097,000 -17,048,000 -9,067,000 -9,412,000 -6,698,000 -7,944,000 -9,088,000 -7,809,000 -3,411,000 -5,300,000 -615,000 -1,639,000 -424,000 -6,051,000 -9,833,000 -10,198,000 9,862,000 210,000 4,558,000 2,168,000 5,621,000 -2,223,000 13,000 4,766,000 -8,669,000 -16,381,000 1,138,000 4,187,000 2,818,000 -336,000 -298,000 8,317,000 5,005,000 -1,431,000 2,299,000 6,553,000 2,944,000 1,612,000 -1,680,000 -1,905,000 -8,747,000 -2,501,000 -2,511,000 897,000 2,425,000 -6,359,000 -1,304,000 -4,100,000 -9,751,000 -4,324,000 -6,383,000   -4,931,000 -2,240,000  
          capital expenditures
        1,202,000 6,782,000 -8,892,000 -9,906,000 -9,657,000 -15,836,000 -34,100,000 -25,517,000 3,250,000 -14,451,000 -18,757,000 -14,427,000 -9,931,000 -15,444,000 -8,590,000 -1,882,000 -9,050,000 -7,439,000 -7,172,000 -8,617,000 -6,299,000 -3,356,000 -1,332,000 -2,617,000 -7,644,000 -1,213,000 -283,000 -3,554,000 -164,000 -1,961,000 105,000 -411,000 29,000 -3,371,000 -1,977,000 -1,606,000 -1,600,000 -4,005,000 -1,686,000 -3,509,000 -1,482,000 -3,794,000 -3,462,000 -3,549,000 -2,876,000 -3,081,000 -1,794,000 -3,377,000 -3,294,000 -5,162,000 1,249,000 -3,636,000 -3,964,000 -4,479,000 -3,519,000 -173,000 -4,151,000 -2,219,000 -1,663,000 -2,371,000 -5,584,000 -4,928,000 -1,145,000 -2,166,000 -3,009,000 252,000 -2,914,000 -2,904,000 -4,669,000 -2,515,000 -1,585,000   -421,000  
          free cash flows
        2,493,000 27,464,000 5,148,000 5,642,000 -14,696,000 10,523,000 -21,178,000 -45,494,000 -63,955,000 -21,754,000 -31,736,000 -36,629,000 -32,751,000 -8,403,000 -24,621,000 -42,782,000 -33,302,000 -16,738,000 -32,516,000 -23,945,000 -25,776,000 -15,345,000 -15,838,000 -16,453,000 -18,380,000 -11,684,000 -17,056,000 -7,911,000 -8,227,000 -12,642,000 -7,973,000 -5,372,000 -5,195,000 -1,026,000 -1,610,000 -3,795,000 -8,028,000 -11,439,000 -11,798,000 5,857,000 -1,476,000 1,049,000 686,000 1,827,000 -5,685,000 -3,536,000 1,890,000 -11,750,000 -18,175,000 -2,239,000 893,000 -2,344,000 913,000 -3,934,000 4,353,000 526,000 -4,950,000 2,126,000 2,402,000 725,000 -51,000 -4,051,000 -7,489,000 -13,675,000 -3,646,000 -4,677,000 -2,112,000 2,425,000 -6,107,000 -4,218,000 -7,004,000 -14,420,000 -6,839,000 -7,968,000   -5,352,000 -2,240,000  
          investing activities:
                                                                                       
          purchase of property and equipment
        -12,091,000  -9,233,000 -10,324,000 -9,934,000  -15,836,000 -34,100,000 -31,312,000  -19,374,000 -19,139,000 -16,278,000  -9,646,000 -13,081,000 -13,257,000  -12,918,000                                                             
          note receivable
        -5,000,000                                                                               
          purchase of intangible assets
        -2,223,000 -2,001,000 -1,658,000 -1,849,000 -1,678,000 -1,771,000 -4,042,000 -1,794,000 -2,306,000 -2,496,000 -2,009,000 -1,424,000 -538,000 -1,366,000 -5,982,000 -1,329,000 -150,000                                 -250,000 -250,000 -250,000 -925,000 -175,000   -245,000 -445,000 -1,800,000       -1,000   33,000 -18,000 -2,627,000   
          net cash from investing activities
        -19,894,000 -15,735,000 -13,891,000 -12,173,000 -11,612,000 -3,746,000 -19,878,000 -35,894,000 -33,618,000 -28,213,000 -21,383,000 -75,563,000 -16,816,000 -14,835,000 -15,628,000 -14,410,000 -13,407,000 -19,997,000 -12,918,000 -98,853,000 -25,994,000 -11,018,000 -5,863,000 -4,349,000 -2,629,000 -2,595,000 -6,720,000 -2,649,000 -1,068,000 -3,467,000 -1,819,000 -2,301,000 -14,082,000 -179,000 -968,000 -3,371,000 -1,977,000 -1,960,000 68,294,000 -3,205,000 -1,170,000 -3,509,000 -1,482,000 -3,794,000 -3,462,000 -3,549,000 -2,876,000 -3,081,000 -1,494,000 -3,377,000 -3,544,000 -9,412,000 -2,769,000 -6,561,000 -4,187,000 -5,129,000 -3,519,000 -418,000 -4,281,000 -2,344,000 -2,473,000 -4,171,000 -5,584,000 -5,099,000 444,000 -2,106,000 -4,362,000 -3,756,000 -2,509,000 -1,961,000 -1,602,000 -5,058,000 -515,000 -485,000   -5,048,000 -3,676,000  
          financing activities:
                                                                                       
          repayment of revolving credit facility
        -2,994,000 -3,368,000 -3,700,000 -4,092,000 -52,800,000  -26,400,000 -42,000,000 -42,000,000  -35,000,000 -20,000,000 -27,500,000                                                                   
          proceeds from revolving credit facility
        2,747,000 2,994,000 3,368,000 3,700,000 4,092,000  33,775,000 46,400,000 42,000,000  37,000,000                                                                     
          payments related to tax witholdings for share-based compensation
        -2,166,000                                                                               
          proceeds from issuance of convertible notes
         392,850,000                                                                          
          repurchase of convertible notes
         -268,231,000                                                                           
          purchase of capped calls
         -42,485,000                                                                          
          net cash from financing activities
        -1,774,000 206,000 -1,313,000 366,000 30,759,000 50,642,000 6,694,000 3,242,000 -4,370,000 151,571,000 60,325,000 77,913,000 67,110,000 1,013,000 29,444,000 -1,926,000 2,697,000 -487,000 183,684,000 -2,007,000 130,776,000 109,821,000 -90,000 21,137,000 -39,000 964,000 55,443,000 11,478,000 -3,702,000 6,470,000 -129,000 2,961,000 44,583,000 7,801,000 -1,205,000 -2,532,000 13,757,000 4,530,000 -42,167,000 -4,218,000 -1,537,000 17,000 809,000 -3,652,000 -3,706,000 3,677,000 -431,000 7,176,000 20,312,000 5,126,000 5,173,000 -30,000 418,000 2,984,000 -241,000 5,062,000 671,000 -3,930,000 -1,833,000 -378,000 -774,000 -217,000 -1,497,000 40,017,000 4,762,000 384,000 -2,022,000 11,063,000 844,000 10,835,000 3,520,000 1,035,000 6,019,000 -957,000 31,443,000 -362,000 1,195,000 1,451,000 -653,000 
          effect of exchange rate changes on cash
        -517,000 -88,000 -158,000 78,000 296,000 445,000 -326,000 -211,000 -459,000 90,000 -151,000 -156,000 32,000 809,000 -484,000 -668,000 -14,000 -1,280,000 -13,000 2,810,000 -2,806,000 12,000 7,000 6,000 69,000 -32,000 -38,000 20,000 79,000 28,000 -44,000 18,000 -22,000 -10,000 301,000 -143,000 96,000 1,135,000 629,000 -878,000 -971,000 -339,000 109,000 -677,000 1,056,000 -575,000 -273,000 -207,000 -18,000                               
          net change in cash and cash equivalents
        -20,894,000 5,065,000 -1,322,000 3,819,000 14,404,000 57,864,000 -18,852,000 -44,257,000 -76,885,000                                                                       
          cash and cash equivalents at beginning of period
        160,806,000  138,840,000  220,970,000  84,696,000  187,248,000                                  22,241,000 20,666,000 23,168,000 10,085,000 18,315,000 25,843,000 16,943,000 
          cash and cash equivalents at end of period
        139,912,000  -1,322,000 3,819,000 153,244,000  -18,852,000 -44,257,000 144,085,000  21,506,000 -15,678,000 116,698,000  -1,358,000 -44,342,000 151,812,000                                  5,706,000 -6,345,000 19,293,000 -3,700,000 3,918,000 5,164,000 16,859,000 -1,478,000 383,000 284,000 21,477,000 -5,686,000 -9,554,000 25,746,000 12,662,000 -4,025,000 -5,621,000 9,644,000 10,087,000 7,441,000 -2,197,000 -13,833,000 26,904,000 -7,818,000 27,412,000 -1,841,000 8,090,000 -4,417,000 -3,660,000 
          supplemental disclosure of cash flow information:
                                                                                       
          cash paid for interest
        6,549,000 5,054,000 7,049,000 5,187,000 6,530,000 4,974,000 5,584,000 4,295,000 5,463,000 6,067,000 4,362,000 3,106,000 3,734,000 1,137,000 753,000 718,000 1,252,000 730,000 821,000 1,693,000 1,783,000 1,399,000 1,397,000 1,888,000 1,646,000 1,627,000 1,628,000 1,357,000 1,357,000 1,754,000 1,105,000 1,190,000 1,092,000  1,131,000                  936,000  692,000              527,000           
          supplemental disclosure of noncash activities:
                                                                                       
          purchases of property and equipment in accounts payable and accrued expenses
        13,293,000 6,782,000 341,000 418,000 277,000    5,795,000 3,250,000 4,923,000 382,000 1,851,000  -285,000 -2,363,000 4,667,000                                                               
          purchase of intangible assets in accrued expenses and other long-term liabilities
        2,750,000                                                                               
          financed insurance
        1,020,000 1,347,000 1,156,000 1,328,000 158,000 184,000 1,617,000                                                               
          recognition of lease liability
        966,000            1,514,000    244,000 1,654,000 21,505,000                                                           
          recognition of derivative liability
         -1,000 124,062,000                                                                           
          purchases of property and equipment
                            -15,202,000 -10,263,000 -5,890,000 -4,349,000 -2,629,000 -2,595,000 -6,720,000 -2,649,000 -1,068,000 -3,217,000 -910,000 -1,977,000 -410,000 -411,000 -1,837,000 -3,371,000 -1,977,000 -1,606,000 -1,600,000 -4,005,000 -1,686,000 -3,509,000 -1,482,000 -3,794,000 -3,462,000 -3,549,000 -2,876,000 -3,081,000 -1,794,000 -3,377,000 -3,294,000 -5,162,000 -2,519,000 -3,636,000 -4,012,000 -4,479,000 -3,519,000 -173,000 -4,151,000 -2,219,000 -1,663,000 -2,371,000 -5,584,000 -4,928,000 -1,145,000 -2,166,000 -3,009,000             
          acquisition of business, net of cash acquired
                                                                                     
          cash paid for equity investment
                                                                                      
          payment of debt issuance costs
               -128,000 -3,193,000 -347,000                                                                 
          proceeds from term debt, net of debt discount
                                                                                       
          net cash received (paid for) common stock exercises
                                                                                       
          proceeds from common stock offerings, net of offering costs
                                                                                       
          repayment of oceanes
                                                                                     
          cash and cash equivalents at beginning of year
                                                                                       
          cash and cash equivalents at end of year
                                                                                       
          cash paid for income taxes
         41,000     86,000 41,000   5,000   -2,000 204,000 21,000 4,000 20,000 141,000 25,000 59,000 79,000 23,000 25,000 37,000 66,000 6,000  21,000                  958,000  210,000              152,000           
          supplemental disclosure of noncash investing and financing activities:
                                                                                       
          purchases of intangible assets in accrued expenses and other long-term liabilities
                                                                                       
          common stock issued for asset acquisition
                                                                                      
          net cash paid for common stock exercises
          -54,000 2,358,000 -3,003,000 4,172,000 291,000 -326,000 -4,697,000 1,270,000                                                                      
          recognition of lease liabilities
             406,000                                                                         
          purchase of intangible assets in accrued expenses
           -950,000 2,631,000                                                                           
          accrued expenses and other current liabilities
                        -1,268,000 10,326,000 -2,837,000 -3,464,000 2,958,000                                                           
          proceeds from revolving credit facility and line of credit
                                                                                       
          repayment of revolving credit facility and line of credit
                                                                                       
          debt issuance costs
                     2,413,000               -300,000                                                   
          financed property and equipment
                                                                                       
          purchases of intangible assets
                                                                                       
          modification of lease liability for lease amendment
                                                                                     
          acquisition of business
                                                                                      
          proceeds from financed insurance
              1,156,000  1,328,000  184,000 1,617,000                                                               
          proceeds from term loan, net of debt discount
                  50,000,000 -27,000 98,500,000                                                                   
          repayment of debt issuance costs
                                                                                       
          proceeds from common stock offering, net of offering costs
                                                                                       
          purchase of property and equipment in accounts payable and accrued expenses
                                                                                       
          proceeds from common stock offering
                                                                                       
          impairment of investment
                                                                                       
          purchase of oceane
                                                                                     
          cash paid for investments
                                                                                     
          settlement of forward contract
                         -399,000                                                             
          repurchase of common stock
                                                                                      
          repayment of squadron medical term loan
                                                                                      
          repayment of inventory financing agreement
                                                                                      
          ppp loan forgiveness
                                                                                      
          financed inventory
                                                                                       
          net increase in cash and cash equivalents
                  21,506,000 -15,678,000 32,002,000    -35,436,000                                  5,706,000   -3,700,000 3,918,000   -1,478,000 383,000 284,000 -1,691,000 -5,686,000 -9,554,000 25,746,000 2,577,000   9,644,000 -8,228,000 7,441,000   1,061,000 -7,818,000 27,412,000   -4,417,000  
          net cash received from common stock exercises
                   -445,000 -1,106,000   -1,083,000 1,301,000 -138,000 -2,781,000 -1,996,000 -1,048,000                                                           
          cash received from sale of assets
                                             800,000 516,000     300,000                               
          proceeds from term debt
                                                                                       
          purchases of property and equipment in accounts payable
                         -1,882,000 3,868,000 -7,439,000 8,030,000 1,646,000 -409,000 993,000 1,297,000 -22,000 -924,000 1,436,000 785,000 -337,000 746,000 16,000 515,000  1,866,000                  3,768,000  48,000                         
          common stock warrants issued with term loan draw
                             -12,000                                                       
          common stock issued for partial extinguishment of debt
                                                                                       
          loss on extinguishment of debt
                                                                                     
          net cash paid from common stock exercises
                                                                                       
          principal payments on finance lease obligations
                      -43,000                                                                 
          principal payments on term loan and notes payable
                      -332,000       -2,000                                                         
          net decrease in cash and cash equivalents
                                                            -2,948,000    -3,807,000                    -8,853,000   
          lease liability
                        -562,000 -18,000 194,000 -57,000 31,000 -337,000 -331,000 -320,000 -324,000 -289,000 -111,000 -271,000 2,910,000                                                   
          purchase of debt and equity securities
                                                                                       
          cash paid for acquisition of intangible assets
                                     -250,000                                                  
          borrowings under lines of credit
                             12,911,000 29,544,000 32,987,000 27,503,000 27,787,000 26,433,000 22,655,000 23,304,000 22,067,000 22,433,000 25,697,000 23,433,000 22,919,000 24,195,000 24,241,000 24,086,000 35,276,000 34,879,000 36,060,000 32,060,000 34,512,000 38,951,000 41,001,000 42,965,000 40,080,000 39,021,000 45,339,000 40,537,000 34,077,000 34,669,000 38,351,000 35,738,000 43,560,000 3,583,000 688,000 1,232,000 430,000 17,564,000 1,000,000 1,200,000 410,000 1,900,000 1,928,000 1,940,000 11,350,000 4,250,000 8,500,000       
          repayments under lines of credit
                             -26,207,000 -30,408,000 -31,773,000 -26,673,000 -27,666,000 -26,822,000 -21,412,000 -21,947,000 -22,456,000 -24,178,000 -24,387,000 -23,387,000 -24,243,000 -26,426,000 -23,952,000 -39,877,000 -37,085,000 -33,878,000 -34,213,000 -34,268,000 -35,859,000 -40,227,000 -41,038,000 -42,311,000 -36,156,000 -36,601,000 -38,838,000 -63,091,000 -33,429,000 -33,497,000 -34,628,000 -35,269,000 -29,019,000 -937,000 -14,232,000 -2,684,000 -430,000 -1,263,000 -1,500,000 -296,000 -455,000 -1,323,000 -255,000 -500,000 -12,750,000 -811,000 -1,869,000 -21,047,000     
          proceeds from issuance of term debt
                             -4,000 91,000                                                       
          common stock issued for development of intangible assets
                                                                                       
          amortization of debt issuance costs
                                                                                       
          provision for excess and obsolete inventory
                          2,525,000 2,221,000 2,096,000   1,712,000 1,722,000    1,997,000  -600,000 867,000 1,345,000  748,000   1,175,000   645,000       625,000 713,000 810,000        1,199,000 1,963,000 710,000 692,000 942,000 796,000 650,000 393,000 911,000 510,000 296,000 210,000 1,339,000 434,000 778,000 517,000       
          loss on disposal of instruments
                          280,000 320,000 369,000 217,000 137,000 112,000 32,000     405,000   -131,000                                               
          changes in operating assets and liabilities, net of effects of acquisition:
                                                                                       
          proceeds from public offering
                          -10,000 131,838,000     -126,000                                                      
          net increase in cash
                            83,372,000 92,087,000    -10,730,000 39,273,000 2,151,000 -12,635,000 -6,057,000 -9,801,000 -2,733,000 25,179,000 6,997,000   5,825,000 -6,128,000       -8,335,000    2,419,000                               
          cash at beginning of period
                                               11,229,000 19,735,000 21,345,000                               
          cash at end of period
                                               1,561,000 7,761,000 727,000 1,604,000 -2,502,000 11,400,000 -434,000 1,186,000 -4,781,000 23,764,000                               
          common stock issued with term loan draw
                                                                                       
          provision for doubtful accounts
                               27,000 -5,000    66,000  21,000 55,000 55,000  -73,000      195,000       49,000 178,000 179,000        500,000 478,000 110,000 6,000         214,000 10,000 61,000 45,000       
          principal payments on capital lease obligations
                           12,000 -14,000 -8,000 -6,000 -10,000 -8,000 -5,000 -10,000 -7,000 -5,000 -9,000 -27,000 -29,000 -31,000 -219,000 -60,000 -134,000 -159,000 -192,000 -206,000 -202,000 -198,000 -192,000 -171,000 -188,000 -196,000 -161,000 -150,000 -335,000 -120,000    -124,000 -301,000   -110,000 -29,000 -43,000 -49,000 -22,000 -45,000 -33,000 -78,000 -18,000 -64,000 -81,000 -99,000 -98,000 -96,000 -120,000 -126,000 -137,000 -140,000    -131,000  
          net decrease in cash
                               3,697,000 -19,647,000               1,561,000 -3,468,000 727,000 1,604,000    1,186,000                                 
          cash at beginning of period, including discontinued operations
                           107,765,000  47,113,000  29,054,000  22,466,000  -159,000 19,752,000                                           
          cash at end of period, including discontinued operations
                           -114,556,000 191,137,000  -15,485,000 3,697,000 27,466,000  39,273,000 2,151,000 16,419,000  -9,801,000 -2,733,000 47,645,000  -3,670,000 -6,470,000 25,577,000                                           
          supplemental disclosure of noncash investing activities:
                                                                                       
          loss on impairment of intangible asset
                            150,000                                                           
          loss on fair value investments
                            149,000                                                           
          cash paid for investment in eos
                            -9,081,000                                                           
          loss on forward contract settlement
                            -1,711,000                                                           
          recognition of right-of-use asset
                            21,570,000                                                           
          deferred income tax benefit
                                 -440,000 -2,000 4,000                      -113,000   -1,913,000 499,000    -684,000                     
          beneficial conversion feature from convertible notes
                                 242,000                                                   
          accretion to contingent consideration
                                 289,000 200,000 546,000                                                 
          other long-term assets
                                 -444,000 -174,000 -78,000 -2,612,000                                                   
          accrued expenses and other
                             4,251,000 7,110,000 94,000 -2,643,000 3,334,000 2,112,000 2,272,000 -1,071,000 1,993,000 -2,084,000 2,026,000 -258,000 5,304,000 -2,342,000 -3,343,000 -5,867,000 -3,731,000 1,987,000 -1,147,000 -607,000 6,279,000 -2,861,000 -3,071,000 -6,712,000 -446,000 -3,424,000 -27,276,000 -3,984,000 54,999,000 5,602,000 -1,112,000 -4,318,000 1,896,000 -2,496,000 3,801,000 -4,965,000 2,889,000 -818,000 -1,472,000 647,000 -3,479,000 1,371,000 -3,309,000 2,826,000  -3,538,000 1,756,000 1,892,000  1,966,000 2,630,000 -1,688,000 2,180,000 1,102,000 -1,020,000 -457,000 2,224,000 -1,132,000 
          cash received from sale of equipment
                                     176,000 172,000                                               
          proceeds from sale of common stock
                             2,137,000 -175,000 546,000 833,000 -96,000 672,000                                                     
          cash at beginning of year
                                                                                       
          cash at end of year
                                                                                       
          common stock issued for achievement of safeop contingent consideration
                                 2,889,000                                                   
          net income
                                 -17,031,000 -14,567,000          -5,515,000       -3,947,000 -4,561,000 -273,000      -4,661,000 -2,649,000 -5,355,000 -2,469,000 -6,374,000 -1,261,000                       
          adjustments to reconcile net income to net cash from operating activities:
                                                                                       
          amortization of right-of-use asset
                              344,000 268,000 259,000 252,000 237,000 224,000 217,000                                                   
          benefit from doubtful accounts
                                 52,000 68,000          12,000         79,000      127,000 57,000 1,000 -70,000 532,000 396,000                       
          benefit from excess and obsolete inventory
                                 2,173,000 2,328,000          306,000       991,000 583,000 986,000      1,403,000 1,698,000 2,678,000 1,170,000 1,965,000 845,000                       
          level 1:
                                                                                       
          gain on settlement
                                     -6,168,000                                               
          deferred revenue
                                     -64,000                                       -1,004,000 1,477,000         
          cash paid for acquisition of safeop surgical, inc.
                                     -759,000 -500,000 -13,844,000                                               
          common stock and warrants issued for the acquisition of safeop
                                                                                       
          gain on disposal of instruments
                                  412,000 341,000 -275,000                                                   
          principal payments on term loan
                                  -23,000 -23,000 -3,022,000  -1,475,000                                                 
          proceeds from sale of stock
                                    14,000 348,000 16,000 4,279,000 47,259,000  -420,000 158,000 17,472,000  -1,000                                         
          provision (recovery) for doubtful accounts
                                                                                       
          (recovery) benefit from excess and obsolete inventory
                                                                                       
          gain on sale of assets
                                                                                      
          gain from change in estimated fair value of warrants
                                                                                       
          issuance of warrants upon execution of term loan
                                                                                       
          reclassification of warrant liabilities to equity
                                                                                       
          common stock issued for acquisition of intangible assets
                                                                                       
          capital lease additions included in property and equipment
                                                                                       
          subscription receivable
                                                                                       
          deferred income tax expense
                                      11,000 -1,269,000 31,000      50,000 -76,000  -1,686,000 133,000 233,000  -16,000 248,000 106,000        162,000    -830,000 -844,000                  
          other non-cash items
                                           -600,000 994,000 146,000 -540,000 832,000 -12,000 620,000 -5,570,000 720,000 -133,000 -742,000        268,000                          
          deferred revenues
                                        -22,000  43,000     68,000 80,000  -94,000 -264,000 30,000  -194,000 211,000 -18,000  26,000 -133,000 -46,000  306,000 168,000 -285,000  79,000 25,000 -130,000  1,685,000 -319,000 -517,000  -798,000 364,000 643,000           
          principal payments on notes payable and term loan
                                        -900,000 -2,266,000 1,029,000 -1,232,000 -1,325,000  -49,215,000 -2,265,000 -2,340,000                                       
          transaction related expenses in accounts payable
                                        542,000                                               
          goodwill and intangible assets impairment
                                                                                       
          interest expense related to amortization of debt discount and debt issuance costs
                                           706,000 717,000 310,000 760,000 1,128,000 1,432,000 1,065,000 1,136,000 1,100,000 1,394,000 2,346,000 1,998,000 1,926,000 430,000 83,000 76,000 80,000 129,000 70,000 78,000 669,000 102,000 94,000 92,000 92,000 97,000 608,000 278,000 297,000 147,000  147,000 147,000 150,000           
          (recovery) benefit from doubtful accounts
                                                                                       
          gain on sale of business
                                             -2,574,000                                          
          loss on sale of instruments
                                                                                       
          restricted cash
                                             150,000 1,100,000 1,100,000 1,100,000 1,100,000 1,100,000 1,100,000 -4,749,000 15,749,000 -17,750,000                               
          other long term liabilities
                                                                                       
          proceeds from sale of business
                                             -104,000                                          
          issuance of preferred and common stock
                                                                                       
          proceeds from issuance of notes payable
                                                                             13,921,000 1,131,000   -7,000 584,000 1,618,000 -402,000 
          cash at beginning of year, including discontinued operations
                                                                                       
          cash at end of year, including discontinued operations
                                                                                       
          impairment of goodwill and intangible assets
                                                                                       
          proceeds from/(payments on) notes payable
                                                                                       
          cashless warrant conversion
                                                                                       
          in-process research and development
                                                                                       
          deferred income tax provision
                                                                                       
          issuance of common stock
                                                                                       
          principal payments on notes payable
                                                 -2,013,000 -1,812,000 -2,117,000 -2,234,000 -2,001,000 -935,000 -1,413,000 -1,488,000    -630,000 -498,000   -1,881,000 -357,000 -345,000 -425,000 -753,000 -15,995,000 -2,481,000 -2,820,000 -1,972,000 -1,070,000 -606,000 -395,000 -498,000 -1,590,000 -930,000 -654,000 -497,000 -603,000 -383,000 -362,000 -900,000 -1,525,000  
          provision for (recovery of) doubtful accounts
                                                                                       
          proceeds from notes payable
                                                      5,000,000 19,500,000                               
          adjustments to reconcile net loss to net cash from by operating activities:
                                                                                       
          cash paid for acquisitions
                                                                                     
          exercise of stock options
                                                             60,000 16,000 7,000 96,000 1,000 2,000 17,000 102,000 92,000 7,000              
          goodwill and intangible impairment
                                                                                       
          non-cash in-process research and development expenses
                                                                                       
          adjustments to reconcile net income to net cash from by operating activities:
                                                                                       
          other noncash items
                                                       1,833,000 -335,000  187,000                             
          litigation settlement
                                                                                       
          principal payments on notes payable and capital lease obligations
                                                          -273,000                             
          effect of exchange rate changes on cash and cash equivalents
                                                          -110,000 279,000 -261,000 175,000 29,000 226,000 472,000 571,000 -56,000 62,000 -56,000 382,000 -568,000 -425,000 -128,000 208,000 -134,000 -88,000 -204,000 -129,000 -15,000 -59,000 -119,000 7,000 -78,000 -103,000 -69,000 48,000 97,000 
          supplemental cash flow information:
                                                                                       
          property and equipment purchased under capital lease
                                                              501,000                         
          deferred income tax (benefit) expense
                                                            -204,000                           
          gain on sale of imc co.
                                                                                     
          cash received from acquisition of scient’x
                                                                                       
          proceeds from sale of imc co.
                                                                                     
          net proceeds from issuance of common stock
                                                                     43,113,000 6,546,000 66,000 -43,000           2,000 
          purchase of noncontrolling interest
                                                                                       
          cash paid for acquisition of brazilian subsidiary
                                                                 -130,000 -125,000 -365,000                   
          in-process research and development paid in stock
                                                                        -2,000 2,663,000 350,000 650,000      
          loss on sale of property and equipment
                                                                                       
          proceeds from sale of noas medical company
                                                                                       
          cash received in acquisition of scient’x
                                                                     1,589,000               
          return of scient’x license fee
                                                                                       
          proceeds from sale of property and equipment
                                                                                       
          certificate of deposit proceeds
                                                                                       
          repurchase of stock options
                                                                                       
          provision for (recoveries from) doubtful accounts
                                                                      33,000 717,000 14,000 25,000 5,000 -25,000           
          gain on sale of property and equipment
                                                                          -59,000             
          proceeds from sale of noas investment
                                                                          383,000           
          deferred income taxes
                                                                       -220,000 35,000 31,000 28,000 47,000 35,000 36,000 35,000 36,000 294,000     283,000  
          purchase of intangible asset
                                                                                       
          interest expense related to amortization of debt discount, debt issuance costs and revaluation of put right
                                                                                       
          accrued expenses and other liabilities
                                                                                       
          acquisitions of japan ortho medical, net of cash acquired
                                                                                       
          acquisition of alphatec manufacturing, inc., net of cash acquired
                                                                                     
          proceeds from sale of (investment in) noas medical company
                                                                                       
          return (purchase) of scient’x license fee
                                                                                       
          escrow proceeds
                                                                                 952,000   
          scient’x license fee repayment
                                                                                       
          sale of certificate of deposit
                                                                               2,000,000       
          accrued litigation settlement
                                                                                11,000,000       
          purchases of instruments, property and equipment
                                                                            -2,892,000 -2,914,000 -2,904,000 -4,669,000 -2,515,000 -1,585,000 -1,858,000 -1,508,000 -421,000   
          purchase of instruments, property and equipment in accounts payable
                                                                            3,144,000           
          income taxes receivable
                                                                                  -9,000 -20,000 73,000  
          acquisition of japan ortho medical, net of cash acquired
                                                                                       
          investment in noas medical company
                                                                                     
          acquisition of certain assets and liabilities of cortek, inc., net of cash acquired
                                                                                       
          proceeds from issuance of rolling common, series c common and preferred stock
                                                                                     -2,000 
          repayment of supply agreement obligation
                                                                                      
          cash paid for redemption of redeemable convertible preferred stock
                                                                                       
          repayment of stockholder notes receivable
                                                                                     
          interest expense related to amortization of debt discount and revaluation of put right
                                                                                 58,000 91,000 -564,000 -89,000 
          investment (sale) - certificate of deposit
                                                                                       
          revaluation of put right
                                                                                       
          investment in certificate of deposit
                                                                                    -2,000,000   
          net (decrease) in cash and cash equivalents
                                                                                       
          write-off of purchased in-process research and development
                                                                                       
          allowance for doubtful accounts
                                                                                       
          allowance for excess and obsolete inventory
                                                                                       
          acquisition of certain assest and liabilities of cortek, inc., net of cash acquired
                                                                                      
          acquisition of ishibe medical co. ltd, net of cash acquired
                                                                                       
          deferred costs paid in connection with initial public offering
                                                                                       
          stock redemption
                                                                                     1,000  
          acquisition of japan ortho medical (formerly blues medica), net of cash acquired
                                                                                       
          increase in restricted cash
                                                                                      
          net proceeds from the issuance of common stock
                                                                                       
          accretion to redemption value of redeemable stock
                                                                                       
          purchases of property and equipment through capital leases
                                                                                       
          net cash (used) in operating activities
                                                                                       
          acquisition of blues medica, net of cash acquired
                                                                                       
          net cash (used) in investing activities
                                                                                       
          net proceeds from common stock subscription
                                                                                   1,119,000   
          borrowings (repayments) under lines of credit
                                                                                    -560,000   
          advances received on common stock sales
                                                                                       
          net borrowings under lines of credit
                                                                                       
          net cash used in operating activities
                                                                                       
          net cash used in investing activities
                                                                                       
          net increase (decrease) in cash and cash equivalents